Skip Navigation LinksHome > January 2, 2006 - Volume 20 - Issue 1 > Herpes simplex virus 2 infection increases HIV acquisition i...
AIDS:
Epidemiology and Social

Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies

Freeman, Esther Ea; Weiss, Helen Aa; Glynn, Judith Ra; Cross, Pamela La; Whitworth, James Aa,b; Hayes, Richard Ja

Free Access
Article Outline
Collapse Box

Author Information

From the aInfectious Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine

bWellcome Trust, London, UK.

Received 9 March, 2005

Revised 13 June, 2005

Accepted 27 July, 2005

Correspondence to E. Freeman. Harvard Medical School, Francis Weld Peabody Society, 260 Longwood Ave., Boston MA 02115, USA. E-mail: esther_freeman@hms.harvard.edu

Collapse Box

Abstract

Objective: To estimate the sex-specific effect of herpes simplex virus type 2 (HSV-2) on the acquisition of HIV infection.

Background: The increased number of longitudinal studies available since the last meta-analysis was published allows for the calculation of age- and sexual behaviour-adjusted relative risks (RR) separately for men and women.

Design: Systematic review and meta-analysis of longitudinal studies.

Methods: PubMed, Embase and relevant conference abstracts were systematically searched to identify longitudinal studies in which the relative timing of HSV-2 infection and HIV infection could be established. Where necessary, authors were contacted for separate estimates in men and women, adjusted for age and a measure of sexual behaviour. Summary adjusted RR were calculated using random-effects meta-analyses where appropriate. Studies on recent HSV-2 incidence as a risk factor for HIV acquisition were also collated.

Results: Of 19 eligible studies identified, 18 adjusted for age and at least one measure of sexual behaviour after author contact. Among these, HSV-2 seropositivity was a statistically significant risk factor for HIV acquisition in general population studies of men [summary adjusted RR, 2.7; 95% confidence interval (CI), 1.9–3.9] and women (RR, 3.1; 95% CI, 1.7–5.6), and among men who have sex with men (RR, 1.7; 95% CI, 1.2–2.4). The effect in high-risk women showed significant heterogeneity, with no overall evidence of an association.

Conclusions: Prevalent HSV-2 infection is associated with a three-fold increased risk of HIV acquisition among both men and women in the general population, suggesting that, in areas of high HSV-2 prevalence, a high proportion of HIV is attributable to HSV-2.

Back to Top | Article Outline

Introduction

Sexually transmitted infections (STI), especially those causing genital ulcer disease, are associated with increased sexual transmission of HIV [1–4]. Recent studies have highlighted the synergy between HIV and herpes simplex virus type 2 (HSV-2), a major cause of genital ulcers [1,5]. Several randomized controlled trials are currently underway to assess the impact of HSV-2 therapy on HIV acquisition and transmission.

The epidemiology of HSV-2 differs between women and men, with a greater probability of transmission from male-to-female than female-to-male [6] and gender-specific differences in the frequency of herpes recurrences [7]. It is, therefore, plausible that the effect of HSV-2 on HIV acquisition may also vary by gender, but there is little published evidence on this.

One previous meta-analysis[1] assessed the effect of HSV-2 infection on HIV acquisition in studies published up until April 1999. Nine longitudinal studies were identified, only one of which was among women. The summary estimate of studies among men showed a positive association between prevalent HSV-2 and HIV acquisition, while the single study among women showed a non-significant negative association [8] but was unadjusted for confounders. Two more recent reviews did not present an updated meta-analysis for either sex [5,9].

The primary objective of this study is systematically to review studies of the gender-specific effect of HSV-2 on HIV acquisition, and to carry out meta-analyses of studies in general populations and in groups at high risk of STI and HIV, adjusted for age and sexual behaviour. The review is limited to longitudinal studies in order to separate the effect of HSV-2 on HIV acquisition from any effect of HIV infection on subsequent acquisition of HSV-2. A secondary objective of the paper is to assess the effect of recently acquired (incident) HSV-2 on HIV acquisition in these populations; a limitation of this secondary objective is that the time sequence of infections is not always as clear.

Back to Top | Article Outline

Methods

Inclusion and exclusion criteria
Types of studies

Cohort and nested case–control studies that assessed the relationship between HSV-2 and HIV infection were eligible for inclusion. Studies in which the relative timing of HSV-2 and HIV infection could not be established were excluded.

Back to Top | Article Outline
Exposure and outcome measures

Studies were eligible if HIV and HSV-2 status was measured in all study participants (not just those who were symptomatic) using appropriate serological tests. Appropriate testing for HSV-2 was considered to be an enzyme-linked immunosorbent assay (ELISA) test or immunoblot test using HSV-2 type-specific glycoprotein G, or a Western blot [10,11]. Appropriate testing for HIV was an ELISA test, Western blot or particle agglutination test, confirmed with a second test.

Back to Top | Article Outline
Language

Abstracts and papers in languages other than English were included and were translated by a fluent speaker of the relevant language.

Back to Top | Article Outline
Statistical requirements

Studies providing an estimate of the relative risk (RR) for HIV infection in HSV-2 seropositive compared with seronegative persons were included. Studies were also included if such an estimate could be calculated from the data. Additionally, authors were contacted whenever it appeared that appropriate data were collected but not presented. Where two publications related to the same study, only the more informative was used.

Back to Top | Article Outline
Search strategy

The PubMED and Embase databases were searched to the first week of June 2004.

For the PubMED search, the following thesaurus terms were first combined with the Boolean operator ‘or’: ‘herpesvirus 2,’ ‘herpes genitalis epidemiology,’ and ‘herpes simplex’ (epidemiology, aetiology, prevention and control, and transmission). Four variations of text words for HSV-2 were then added to broaden the search. In order to identify studies that did not specifically mention HSV-2 in their abstracts, but rather referred to general STI, the thesaurus terms on ‘sexually transmitted diseases’ (epidemiology, aetiology, prevention and control, and transmission) were also included. Then, the search was limited to abstracts also containing information on HIV by adding thesaurus terms ‘HIV seropositivity’ or ‘HIV infections/transmission’ or the text phrase ‘HIV seroconverters’ to the previous search with the Boolean operator ‘anD'. The search also required that the abstracts either contained thesaurus terms for ‘cohort studies’, ‘case–control studies’, or ‘prospective studies’, or contained the appropriate text word for this study type. Only journal articles or letters were eligible. A similar Embase search strategy was also undertaken.

In addition, abstracts from the XIV and the XV International AIDS Conference and the 2003 International Society for Sexually Transmitted Diseases Research Conference were searched on ‘herpes’ and ‘hsv’. Reference lists of included studies were examined for other pertinent studies. In addition, collaborating researchers were asked about any relevant unpublished data.

All identified abstracts were scanned and those clearly meeting exclusion criteria were eliminated at this point. Full-length papers were then retrieved if published or authors were contacted for more information if an abstract was not associated with a full length paper. Two reviewers (E. F. & H. W.) then applied the inclusion and exclusion criteria previously listed to the retrieved studies. Authors were contacted if further information was needed to include the study in this review.

Back to Top | Article Outline
Data extraction

Data were extracted onto standardized forms by the two reviewers. A quality assessment was also performed on each study to assess selection bias, response rates, loss to follow-up, misclassification and adjustment for confounding.

Back to Top | Article Outline
Statistical analysis

Meta-analyses were undertaken using odds ratios for nested case–control studies and rate ratios for cohort studies. Since HIV incidence rates were low in most studies, the odds ratios would approximate the risk ratio. Summary relative risks (RR) values were calculated where appropriate, using random-effects models rather than fixed-effects models [1,12,13]. Evidence for statistical heterogeneity was taken as P ≤ 0.1 [13,14] since the test for statistical heterogeneity lacked power [15].

Age and sexual behaviour were taken to be a-priori confounders of the relationship between HSV-2 seropositivity and subsequent infection with HIV. Measures of sexual behaviour were allowed to vary by study, since different measures were appropriate for different groups such as commercial sex workers or men who have sex with men (MSM). Only RR adjusted for age and at least one measure of sexual behaviour were included in the final meta-analysis.

It had been hypothesized that the effect of HSV-2 on acquisition of HIV might vary between women and men, and that within each sex there might be variation by type of study population. To explore this potential diversity, studies in males were divided into MSM and men in the general population (assumed to be largely heterosexual) since the effect of HSV-2 could vary by mode of HIV transmission. Studies in females were also divided into two groups: women at high risk, consisting of sex workers and bar workers; and women in the general population. High-risk women are more likely to have other STI besides HSV-2 that might enhance HIV acquisition.

Sex-specific Begg funnel plots were used to examine inclusion bias in the systematic review. The most comprehensively adjusted relative risk for each study was used for this investigation. Data management and statistical analyses were undertaken in STATA 8.0 (Stata Corp., College Station, Texas, USA).

A secondary objective of the systematic review was to collate available information on the incident HSV-2 (acquired during the study period) as a risk factor for HIV acquisition in studies retrieved in the review. An a-priori decision was made that results from these studies would not be included in the meta-analysis because of the unclear relative timing of the two infections, but results are presented in a separate table.

Back to Top | Article Outline

Results

Details of selected studies

After removing duplicates, 4426 abstracts were identified through the PubMED and Embase searches. Additionally, 13 abstracts were retrieved from recent international conferences. One further unpublished study and one in press study were identified by collaborating researchers.

Out of a total of 4441 studies, 4361 were excluded as not relevant. Of the 80 full-length papers retrieved or the authors contacted, as appropriate, 37 studies were identified for possible inclusion (Fig. 1). There were 19 studies that met all of the inclusion criteria (Table 1) [8,16–33]; of these 14 were already published in a peer-reviewed journal, two were in press, and three were unpublished (two of which already had abstracts published in conference proceedings). Additional information and data were received from authors of 14 of these included studies. The 18 studies that were excluded failed to meet specific inclusion criteria, had insufficient information provided by the authors or had repetition of data (see Supplementary Table S1, http://www.lshtm.ac.uk/ideu/research/freeman_hsv2.html) [16,34–50].

Fig. 1
Fig. 1
Image Tools
Table 1
Table 1
Image Tools
Table 1
Table 1
Image Tools

Of the 19 studies included in the review (Table 1), RR values adjusted for both a-priori confounders, age and a marker of sexual behaviour (and in some cases for other factors as well) were obtained for 18. One study of MSM did not take confounding into account in the presentation of RR values and was considered unadjusted; this study was included in the review but not the meta-analysis. In total, there were 10 studies in women – 4 in the general population and 6 among high-risk women – and 14 studies in men – 9 in the general population and 5 among MSM. Fourteen studies were conducted in developing countries.

The methodological quality of included studies was assessed and can be seen in Supplementary Table S2 (http://www.lshtm.ac.uk/ideu/research/freeman_hsv2.html). Selection bias was considered, including selection of cases and controls where appropriate. Reporting of loss to follow-up was inconsistent; some retrospective studies only considered loss of data or serum rather than loss of individuals in the initial cohort. In studies that did report on this criterion, there was a broad range of loss to follow-up, ranging from a loss at first return visit of 5 to 38% in studies with active follow-up. Few studies supplied information on proportion of selected individuals agreeing to participate. A range of HIV and HSV-2 tests was used by the different studies, but in no case were potential problems thought to have influenced the association of HSV-2 and HIV; no studies were excluded on this basis.

Back to Top | Article Outline
Effect of HSV-2 seropositivity on HIV acquisition

The RR of HIV acquisition in HSV-2-seropositive compared with HSV-2-negative individuals, adjusted for age and sexual behaviour, is shown in Fig. 2. Among general population studies, the summary estimate of adjusted RR was similar for women [RR, 3.1; 95% confidence interval (CI), 1.7–5.6] and men (RR, 2.7; 95% CI, 1.9–3.9) (Table 2). There was little evidence of heterogeneity among studies of women in the general population. The studies in men all showed a positive association (RR values ranging from 1.3 to 7.5), but there was significant heterogeneity (P = 0.03). Among high-risk women, RR values ranged widely, from 0.50 to 6.3, with significant heterogeneity (P = 0.02). Hence, the summary estimates for these studies should be interpreted with caution. The effect of HSV-2 on HIV acquisition in MSM (RR, 1.7; 95% CI, 1.2–2.4) was lower than in general population males, and this difference was of borderline statistical significance (P = 0.07).

Fig. 2
Fig. 2
Image Tools
Table 2
Table 2
Image Tools

Sex-specific Begg funnel plots of included studies (supplementary Fig. S1, http://www.lshtm.ac.uk/ideu/research/freeman_hsv2.html) plot the natural logarithm of the RR from each study against the logarithm of the study's standard error (a marker of study size). There is little evidence of inclusion bias (i.e., there is no evidence that smaller studies were more likely to be included if they detected large effects).

Back to Top | Article Outline
Effect of incident HSV-2 infection on HIV acquisition

Of the studies in the review, eight either presented a relative risk for incident HSV-2 as a risk factor for HIV seroconversion, or presented data allowing for its calculation. These RR values are presented in Table 3. However, with few exceptions, the majority of HSV-2 and HIV seroconversions were recorded during the same follow-up intervals, so it was impossible to determine which infection occurred first, or whether both infections occurred simultaneously. Also, in contrast to our meta-analyses, very few studies adjusted for confounders such as markers of sexual behaviour. In most [19,24,25,27,32], but not all [30,33] studies, recent HSV-2 seroconverters had a higher risk of HIV acquisition than those who had seroconverted to HSV-2 before the study began (comparing Table 3 with Table 1), but these estimates should be interpreted with caution.

Table 3
Table 3
Image Tools
Back to Top | Article Outline

Discussion

This systematic literature review and meta-analysis shows for the first time that prevalent HSV-2 infection is a statistically significant risk factor for HIV acquisition in both men and women in the general population, after adjusting for confounding by age and sexual behaviour. In general populations, men and women infected with HSV-2 had approximately three times the risk of acquiring HIV. Although there was evidence of heterogeneity in the effect among men in the general population, all nine studies contributing to this male summary estimate found a positive association (RR values ranging from 1.3 to 7.5). In MSM, the effect appeared slightly lower than in general population males. This may be due to chance or it could reflect true differences owing to the different transmission route.

The relationship between prevalent HSV-2 and HIV acquisition was not consistent in studies among high-risk women, with RR values ranging from 0.5 to 6.3. This variation between studies could be due to different prevalences of other STI, which act as cofactors for HIV transmission, since these would increase the rate of HIV acquisition in HSV-2-negative individuals. Alternatively, the difference may be a result of residual confounding, if adjustment for sexual exposure to HIV was more complete in some studies than others.

In comparison with the previous meta-analysis [1], we located 16 additional longitudinal estimates of RR from 11 additional studies. In heterosexual men, the new estimate of the adjusted relative risk was slightly higher than that found from unadjusted or partially adjusted studies in the previous meta-analysis (RR, 2.2; 95% CI, 1.3–3.8 [1]). In MSM, our summary adjusted RR was slightly lower than that reported for unadjusted and partially adjusted studies previously (RR, 2.1; 95% CI, 1.3–3.4 [1]), and, unlike the previous study, did not demonstrate any evidence of statistical heterogeneity.

By limiting our meta-analysis to studies with known time sequence of HSV-2 infection and HIV infection, we tried to minimize any bias owing to HIV effects on subsequent acquisition of HSV-2. However, a time lag exists between acquisition of infection and a positive test for both infections. For HSV-2, median time to a positive test from culture-documented primary HSV-2 episodes is 21–120 days, dependent upon the type of test used [51]. The time sequence could, therefore, be misclassified in either direction. This is a particular problem for the examination of incident HSV-2 as a risk factor for HIV, where exact timings are even more difficult to establish.

Although our analysis concentrated on the effect of prevalent HSV-2, there would have been variation between studies in the proportion of individuals with recent and with more remote HSV-2 infections. Since recent HSV-2 may have a stronger effect on HIV acquisition than does more long-standing HSV-2 infection, owing to greater frequency and severity [7,52] of clinical HSV-2 episodes, studies including more recent HSV-2 infections might be expected to have higher RR values.

It was not possible to assess the effect of very recent (incident) HSV-2 infections directly. Few studies examined incident HSV-2, and most of these recorded HSV-2 and HIV seroconversions during the same follow-up interval; consequently, the sequence of infections could not be established. While these studies are consistent with the hypothesis that recent HSV-2 infection is a stronger risk factor for HIV acquisition than is prevalent HSV-2 infection, problems with the time lag, small study size, long intervals between testing dates and lack of adjustment for confounding make the evidence inconclusive.

We attempted to minimize confounding by requesting that authors adjust their estimates of relative risk by a-priori confounders of age and sexual behaviour. Only studies adjusting for at least these confounders were included in the meta-analysis of the effect of prevalent HSV-2. However, residual confounding, especially by sexual behaviour, which was controlled for in a wide variety of ways by included studies, is a major concern in a meta-analysis of observational studies. Obtaining accurate information on sexual behaviour is extremely difficult. However, in most studies the RR changed little upon adjustment for a wide range of confounders.

Studies also used a wide range of HIV and HSV-2 tests. The sensitivity and specificity vary between different tests, and between the same test used on different populations [53]. Misclassification of HSV-2 status is likely to be non-differential with respect to HIV status, leading to underestimation of the association between HSV-2 and HIV.

Publication bias is unlikely to have played an important role in our study since only 5 of the 23 RR values used were published in the form in which they appear in this analysis. Many RR values were extracted from papers or requested from authors whose papers had been published with a different purpose. In these cases, publication was probably not determined by the strength of the RR of interest to this meta-analysis. The funnel plots of ‘inclusion’ bias showed little evidence of any bias.

Controlling HSV-2 could potentially have a large impact on HIV incidence in areas of high HSV-2 prevalence. In a recent review, HSV-2 prevalence in Africa in random and population-based samples of individuals of reproductive age was found to be 29–71% in women and 5–53% in men [54]. Despite the limitations of calculating population-attributable fractions for infectious diseases based on observational studies, from this range of prevalence values and the summary RR values calculated in this meta-analysis, our results suggest that, in these general populations, potentially 38–60% of new HIV infections may be attributable to prevalent HSV-2 infection in women and 8–49% in men.

HSV-2 antiviral treatment is available and has been shown to significantly reduce HSV-2 transmission between discordant heterosexual couples [55]. The impact of this treatment on HIV incidence is not yet known [56]. Ultimately, the best way to establish causality and to understand the impact of HSV-2 interventions on HIV is to undertake HSV-2 intervention studies; several are currently underway.

Back to Top | Article Outline

Acknowledgements

We would like to thank the authors of studies included in the review, and especially researchers contributing information and further data analyses to this review (listed alphabetically by study group/institution): Scott Holmberg (Centers for Disease Control); Nicolas Nagot (Centre Muraz, Burkina Faso); Eduard Sanders, Nicole Dukers (Ethio-Netherlands AIDS Research Project); Ron Gray (Johns Hopkins University Bloomberg School of Public Health); Steven Reynolds, Mary Shepherd, Sanjay Mehendale (Johns Hopkins University–National AIDS Research Institute India Collaboration); Jim Todd (London School of Hygiene and Tropical Medicine); Gabriele Riedner, Michael Hoelscher (Mbeya Medical Research Programme); Gita Ramjee, Eleanor Gouws, Brian Williams (Medical Research Council, South Africa/UNAIDS/WHO); Willi McFarland, Tim Kellogg (San Francisco Department of Public Health); Peter Kilmarx, Sara Whitehead, Philip Mock, Khanchit Limpakarniarnarat (Thailand MOPH–US CDC Collaboration); Lawrence Kingsley (University of Pittsburgh); Rupert Kaul (University of Toronto); Ludo Lavreys, Jared Baeten, Joel Rakwar (University of Washington/University of Nairobi).

Sponsorship: E. E. Freeman was supported by a Marshall Scholarship; H. A. Weiss is funded by the UK Medical Research Council; J. R. Glynn is supported by the UK Department of Health (Public Health Career Scientist Award).

Back to Top | Article Outline

References

1. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185:45–52.

2. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995; 346:530–536.

3. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3–17.

4. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med 1994; 331:341–346.

5. Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr 2004; 35:435–445.

6. Wald A, Langenberg AG, Link K, Izu AE, Ashley R, Warren T, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA 2001; 285:3100–3106.

7. Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med 1994; 121:847–854.

8. Kilmarx PH, Limpakarnjanarat K, Mastro TD, Saisorn S, Kaewkungwal J, Korattana S, et al. HIV-1 seroconversion in a prospective study of female sex workers in northern Thailand: continued high incidence among brothel-based women. AIDS 1998; 12:1889–1898.

9. Celum C, Levine R, Weaver M, Wald A. Genital herpes and human immunodeficiency virus: double trouble. Bull World Health Organ 2004; 82:447–453.

10. Wald A, Ashley-Morrow R. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clin Infect Dis 2002; 35:S173–S182.

11. van Doornum GJ, Slomka MJ, Buimer M, Groen J, van den Hoek JA, Cairo I, et al. Comparison of a monoclonal antibody-blocking enzyme-linked immunoassay and a strip immunoblot assay for identifying type-specific herpes simplex virus type 2 serological responses. Clin Diagn Lab Immunol 2000; 7:641–644.

12. Cochrane Collaboration. Open Learning Material for Reviewers: Diversity and Heterogeneity. Oxford, UK: Cochrane Library; 2002.

13. Engels EA, Schmid CH, Terrin N, Olkin I, Lau J. Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. Stat Med 2000; 19:1707–1728.

14. Villar J, Mackey ME, Carroli G, Donner A. Meta-analyses in systematic reviews of randomized controlled trials in perinatal medicine: comparison of fixed and random effects models. Stat Med 2001; 20:3635–3647.

15. Takkouche B, Cadarso-Suarez C, Spiegelman D. Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. Am J Epidemiol 1999; 150:206–215.

16. Kamali A, Muhangi L, Quigley M, Whitworth J. Association between prevalence and incidence of herpes simplex virus-2, syphilis, and HIV-1 infection in rural Uganda. XIV International Conference on AIDS. Barcelona, July 2002 [abstract MoOrC1011].

17. Nagot N, Ouedraogo A, Ouangre A, Cartoux M, Defer MC, Meda N, et al. Is STI management among sex workers still able to mitigate the spread of HIV infection in West Africa? J Acquir Immune Defic Syndr 2005; 39:454–458.

18. Ouedraogo A, Nagot N, Ouangre A, Defer MC, Meda N, van de Perre P. Is STI management among sex workers still able to mitigate the spread of HIV infection in West Africa? XV International Conference on AIDS. Bangkok, July 2004 [abstract WePeC6191].

19. Ramjee G, Williams B, Gouws E, van Dyck E, de Deken B, Abdool Karim SS. The impact of incident and prevalent HSV-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa. J Acquir Immune Defic Syndr 2005; 39:333–339.

20. Gray RH, Li X, Wawer MJ, Serwadda D, Sewankambo NK, Wabwire-Mangen F, et al. Determinants of HIV-1 load in subjects with early and later HIV infections, in a general-population cohort of Rakai, Uganda. J Infect Dis 2004; 189:1209–1215.

21. Serwadda D, Gray RH, Sewankambo NK, Wabwire-Mangen F, Chen MZ, Quinn TC, et al. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J Infect Dis 2003; 188:1492–1497.

22. Kaul R, Kimani J, Nagelkerke NJ, Fonck K, Ngugi EN, Keli F, et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA 2004; 291:2555–2562.

23. Kebede Y, Dorigo-Zetsma W, Mengistu Y, Mekonnen Y, Schaap A, Wolday D, et al. Transmission of herpes simplex virus type 2 among factory workers in Ethiopia. J Infect Dis 2004; 190:365–372.

24. Renzi C, Douglas JM Jr, Foster M, Critchlow CW, Ashley-Morrow R, Buchbinder SP, et al. Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men. J Infect Dis 2003; 187:19–25.

25. Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brookmeyer RS, Paranjape RS, et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003; 187:1513–1521.

26. Turner KR, McFarland W, Kellogg TA, Wong E, Page-Shafer K, Louie B, et al. Incidence and prevalence of herpes simplex virus type 2 infection in persons seeking repeat HIV counseling and testing. STD 2003; 30:331–334.

27. McFarland W, Gwanzura L, Bassett MT, Machekano R, Latif AS, Ley C, et al. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. J Infect Dis 1999; 180:1459–1465.

28. Rakwar J, Lavreys L, Thompson ML, Jackson D, Bwayo J, Hassanali S, et al. Cofactors for the acquisition of HIV-1 among heterosexual men: prospective cohort study of trucking company workers in Kenya. AIDS 1999; 13:607–614.

29. Nopkesorn T, Mock PA, Mastro TD, Sangkharomya S, Sweat M, Limpakarnjanarat K, et al. HIV-1 subtype E incidence and sexually transmitted diseases in a cohort of military conscripts in northern Thailand. J Acquir Immune Defic Syndr 1998; 18:372–379.

30. Nelson KE, Eiumtrakul S, Celentano D, Maclean I, Ronald A, Suprasert S, et al. The association of herpes simplex virus type 2 (HSV-2), Haemophilus ducreyi, and syphilis with HIV infection in young men in northern Thailand. J Acquir Immune Defic Syndr 1997; 16:293–300.

31. Kingsley LA, Armstrong J, Rahman A, Ho M, Rinaldo CR Jr. No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men. J Acquir Immune Defic Syndr 1990; 3:773–779.

32. Holmberg SD, Stewart JA, Gerber AR, Byers RH, Lee FK, O'Malley PM, et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 1988; 259:1048–1050.

33. Keet IP, Lee FK, van Griensven GJ, Lange JM, Nahmias A, Coutinho RA. Herpes simplex virus type 2 and other genital ulcerative infections as a risk factor for HIV-1 acquisition. Genitourin Med 1990; 66:330–333.

34. Hanson J, Posner S, Hassig S, Rice J, Farley TA. Assessment of sexually transmitted diseases as risk factors for HIV seroconversion in a New Orleans sexually transmitted disease clinic, 1990–1998. Ann Epidemiol 2005; 15:13–20.

35. Brown JM, Chitsungo S, Chipato T, Morrison C, Padian NS. Prevalence and risk factors for herpes simplex virus type 2 among Zimbabwean women. International Society for Sexually Transmitted Disease Research Congress. Ottawa, July 2003 [abstract 0125].

36. Brown JM, Rungruengthanakit K, Rugpao S, Cornelisse P, Padian NS, Morrison C. Hormonal contraceptive use and incidence of herpes simplex virus type 2 among women in Thailand. XV International Conference on AIDS. Bangkok, July 2004 [abstract ThPeC7385].

37. del Mar Pujades Rodriguez M, Obasi A, Mosha F, Todd J, Brown D, Changalucha J, et al. Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS 2002; 16:451–462.

38. Gray JA, Dore GJ, Li Y, Supawitkul S, Effler P, Kaldor JM. HIV-1 infection among female commercial sex workers in rural Thailand. AIDS 1997; 11:89–94.

39. Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001; 357:1149–1153.

40. Lavreys L, Rakwar JP, Thompson ML, Jackson DJ, Mandaliya K, Chohan BH, et al. Effect of circumcision on incidence of human immunodeficiency virus type 1 and other sexually transmitted diseases: a prospective cohort study of trucking company employees in Kenya. J Infect Dis 1999; 180:330–336.

41. Moses S, Kaul R, Kimani J, Fonck K, Nagelkerke NJ, Keli F, et al. Prevalent HSV-2 infection and risk for HIV seroconversion in a cohort of Kenyan female sex workers enrolled in a randomized controlled trial of antibiotic chemoprophylaxis to reduce HIV incidence. XV International Conference on AIDS. Bangkok, July 2004 [abstract LbOrC24].

42. Page-Shafer K, Veugelers PJ, Moss AR, Strathdee S, Kaldor JM, van Griensven GJ. Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982–1994. Am J Epidemiol 1997; 146:531–542.

43. Ramjee G, Gouws E, van Dyck E, Williams B, Abdool Karim SS. Incidence of herpes simplex virus-2 and HIV among sex workers in Kwazulu-Natal Durban: a relation in time study. XIV International Conference on AIDS. Barcelona, July 2002 [abstract ThPeC7616].

44. Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brookmeyer R, Kulkarni SV, et al. Recent herpes simplex virus type 2 infection and the risk of HIV acquisition in Pune, India. XIV International AIDS Conference. 2002. Barcelona, Spain [abstract MoOrC1012].

45. Reynolds SJ, Risbud AR, Godbole SV, Shepherd ME, Joshi SN, Ghate MV, et al. Comparison of risk factors for incident sexually transmitted infections among men attending STI clinics in Pune, India. XV International Conference on AIDS. Bangkok, July 2004 [abstract ThPpC2097].

46. Salata R, Cornelisse P, Chipato T, Mmiro F, Morrison C, Padian NS, et al. Prevalence and incidence of HIV and sexually transmitted infections among young women in Thailand, Uganda, and Zimbabwe participating in the hormonal contraception and risk of HIV acquisition cohort. XIV International Conference on AIDS. Barcelona, July 2002 [abstract ThPeC7413].

47. Salata R, Cornelisse P, Richardson BA, Chipato T, Mmiro F, Mugerwa RD, et al. Interrelationships between sexually transmitted infections and HIV-1 infection among women in Thailand, Uganda, and Zimbabwe participating in the Hormonal Contraception and Risk of HIV-1 Acquisition Study. XV International Conference on AIDS. Bangkok, July 2004.

48. Sturm P, Moodley P, Connolly C, Sturm AW. Risk factors for the acquisition of HIV-1 and HSV-2 in patients presenting with genital ulcer disease. International Society for Sexually Transmitted Disease Research Congress. Ottawa, July 2003 [abstract 0374].

49. Tabet SR, Krone MR, Paradise MA, Corey L, Stamm WE, Celum CL. Incidence of HIV and sexually transmitted diseases (STD) in a cohort of HIV-negative men who have sex with men (MSM). AIDS 1998; 12:2041–2048.

50. Telzak EE, Chiasson MA, Bevier PJ, Stoneburner RL, Castro KG, Jaffe HW. HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study. Ann Intern Med 1993; 119:1181–1186.

51. Morrow RA, Friedrich D, Krantz E. Performance of the focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes. J Clin Microbiol 2003; 41:5212–5214.

52. Benedetti JK, Zeh J, Corey L. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Ann Intern Med 1999; 131:14–20.

53. van Dyck E, Buve A, Weiss HA, Glynn JR, Brown DW, de Deken B, et al. Performance of commercially available enzyme immunoassays for detection of antibodies against herpes simplex virus type 2 in African populations. J Clin Microbiol 2004; 42:2961–2965.

54. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002; 186(Suppl 1):S3–S28.

55. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, Warren T, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11–20.

56. Celum CL, Robinson NJ, Cohen MS. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. J Infect Dis 2005; 191(Suppl 1):S107–S114.

Cited By:

This article has been cited 263 time(s).

Journal of Virology
Griffithsin Protects Mice from Genital Herpes by Preventing Cell-to-Cell Spread
Nixon, B; Stefanidou, M; Mesquita, PMM; Fakioglu, E; Segarra, T; Rohan, L; Halford, W; Palmer, KE; Herold, BC
Journal of Virology, 87(): 6257-6269.
10.1128/JVI.00012-13
CrossRef
International Journal of Std & AIDS
Partner-concurrency associated with herpes simplex virus 2 infection in young South Africans
Kenyon, C; Colebunders, R; Buve, A; Hens, N
International Journal of Std & AIDS, 24(): 804-812.
10.1177/0956462413482810
CrossRef
Antimicrobial Agents and Chemotherapy
Theaflavin-3,3 '-Digallate and Lactic Acid Combinations Reduce Herpes Simplex Virus Infectivity
Isaacs, CE; Xu, WM
Antimicrobial Agents and Chemotherapy, 57(8): 3806-3814.
10.1128/AAC.00659-13
CrossRef
Cold Spring Harbor Perspectives in Medicine
Behavioral and Biomedical Combination Strategies for HIV Prevention
Bekker, LG; Beyrer, C; Quinn, TC
Cold Spring Harbor Perspectives in Medicine, 2(8): -.
ARTN a007435
CrossRef
Expert Review of Vaccines
Combination of adjuvants: the future of vaccine design
Mount, A; Koernig, S; Silva, A; Drane, D; Maraskovsky, E; Morelli, AB
Expert Review of Vaccines, 12(7): 733-746.
10.1586/14760584.2013.811185
CrossRef
American Journal of Obstetrics and Gynecology
Monitoring vaginal epithelial thickness changes noninvasively in sheep using optical coherence tomography
Vincent, KL; Vargas, G; Wei, JN; Bourne, N; Motamedi, M
American Journal of Obstetrics and Gynecology, 208(4): -.
ARTN 282.e1
CrossRef
International Journal of Std & AIDS
Herpes simplex virus type 2 serological testing at a community court: predictors of test acceptance and seropositivity among female defendants
Roth, AM; Van der Pol, B; Fortenberry, JD; Reece, M; Dodge, B; Certo, D; Zimet, GD
International Journal of Std & AIDS, 24(3): 169-174.
10.1177/0956462412472442
CrossRef
Sexually Transmitted Infections
HIV and STI control in El Salvador: results from an integrated behavioural survey among men who have sex with men
Creswell, J; Guardado, ME; Lee, J; Nieto, AI; Kim, AA; Monterroso, E; Paz-Bailey, G
Sexually Transmitted Infections, 88(8): 633-638.
10.1136/sextrans-2012-050521
CrossRef
International Journal of Std & AIDS
Herpes simplex virus type 2 incidence and associated risk factors among female sex workers in a high HIV-prevalence area of China
Wang, H; Reilly, KH; Smith, MK; Brown, K; Jin, X; Xu, J; Ding, G; Zang, C; Wang, J; Wang, N
International Journal of Std & AIDS, 24(6): 441-446.
10.1177/0956462412472800
CrossRef
Health Reports
Prevalence of Chlamydia trachomatis and herpes simplex virus type 2: Results from the 2009 to 2011 Canadian Health Measures Survey
Rotermann, M; Langlois, KA; Severini, A; Totten, S
Health Reports, 24(4): 10-15.

Public Health Nursing
Parenting Strategies African American Mothers Employ to Decrease Sexual Risk Behaviors in Their Early Adolescent Daughters
Aronowitz, T; Eche, I
Public Health Nursing, 30(4): 279-287.
10.1111/phn.12027
CrossRef
Microbial Pathogenesis
HSV-2 vaccine: Current state and insights into development of a vaccine that targets genital mucosal protection
Roth, K; Ferreira, VH; Kaushic, C
Microbial Pathogenesis, 58(): 45-54.
10.1016/j.micpath.2012.11.001
CrossRef
Tropical Medicine & International Health
Effect of HSV-2 on population-level trends in HIV incidence in Uganda between 1990 and 2007
Biraro, S; Kamali, A; White, R; Karabarinde, A; Ssendagala, JN; Grosskurth, H; Weiss, HA
Tropical Medicine & International Health, 18(): 1257-1266.
10.1111/tmi.12176
CrossRef
Journal of Infectious Diseases
Time to translate new knowledge into practice: A call for a national genital herpes control program
Hook, EW; Leone, P
Journal of Infectious Diseases, 194(1): 6-7.

Jama-Journal of the American Medical Association
Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States
Xu, FJ; Sternberg, MR; Kottiri, BJ; McQuillan, GM; Lee, FK; Nahmias, AJ; Berman, SM; Markowitz, LE
Jama-Journal of the American Medical Association, 296(8): 964-973.

Reproductive Health Matters
HSV-2 infection increases HIV acquisition in men and women
[Anon]
Reproductive Health Matters, 14(): 204.

Journal of Infectious Diseases
A comprehensive murine model to evaluate topical vaginal microbicides: Mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety
Galen, BT; Martin, AP; Hazrati, E; Garin, A; Guzman, E; Wilson, SS; Porter, DD; Lira, SA; Keller, MJ; Herold, BC
Journal of Infectious Diseases, 195(9): 1332-1339.
10.1086/513279
CrossRef
AIDS
Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe
Brown, JM; Wald, A; Hubbard, A; Rungruengthanakit, K; Chipato, T; Rugpao, S; Mmiro, F; Celentano, DD; Salata, RS; Morrison, CS; Richardson, BA; Padian, NS
AIDS, 21(): 1515-1523.

Antiviral Therapy
Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression
Guzman, EM; Cheshenko, N; Shende, V; Keller, MJ; Goyette, N; Juteau, JM; Boivin, G; Vaillant, A; Herold, BC
Antiviral Therapy, 12(8): 1147-1156.

Journal of Infectious Diseases
Low-Level CD4(+) T Cell Activation in HIV-Exposed Seronegative Subjects: Influence of Gender and Condom Use
Camara, M; Dieye, TN; Seydi, M; Diallo, AA; Fall, M; Diaw, PA; Sow, PS; Mboup, S; Kestens, L; Jennes, W
Journal of Infectious Diseases, 201(6): 835-842.
10.1086/651000
CrossRef
International Journal of Std & AIDS
Decline in HIV prevalence among women of childbearing age in Moshi urban, Tanzania
Msuya, SE; Mbizvo, EM; Stray-Pedersen, B; Uriyo, J; Sam, NE; Rusakaniko, S; Hussain, A
International Journal of Std & AIDS, 18(): 680-687.

Bmc Infectious Diseases
Predictors of incident herpes simplex virus type 2 infections in young women at risk for unintended pregnancy in San Francisco
Moss, NJ; Harper, CC; Ahrens, K; Scott, K; Kao, S; Padian, N; Raine, T; Klausner, JD
Bmc Infectious Diseases, 7(): -.
ARTN 113
CrossRef
Journal of Clinical Investigation
The spread, treatment, and prevention of HIV-1: evolution of a global pandemic
Cohen, MS; Hellmann, N; Levy, JA; DeCock, K; Lange, J
Journal of Clinical Investigation, 118(4): 1244-1254.
10.1172/JCI34706
CrossRef
Infectious Disease Clinics of North America
Epidemiology of Infections in Women
Risser, JMH; Risser, WL; Risser, AL
Infectious Disease Clinics of North America, 22(4): 581-+.
10.1016/j.idc.2008.05.001
CrossRef
Asian Biomedicine
Evidence-based strategies for preventing HIV transmission and the Thailand perspective
Duncombe, C; Ananworanich, J; Phanuphak, N; Vermund, SH
Asian Biomedicine, 3(1): 39-51.

Infectious Disease Clinics of North America
Meta-analytical Studies on the Epidemiology, Prevention, and Treatment of Human Immunodeficiency Virus Infection
Vergidis, PI; Falagas, ME; Hamer, DH
Infectious Disease Clinics of North America, 23(2): 295-+.
10.1016/j.idc.2009.01.013
CrossRef
Vaccine
Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein
Reszka, NJ; Dudek, T; Knipe, DM
Vaccine, 28(): 2754-2762.
10.1016/j.vaccine.2010.01.030
CrossRef
Science Translational Medicine
Frequent Release of Low Amounts of Herpes Simplex Virus from Neurons: Results of a Mathematical Model
Schiffer, JT; Abu-Raddad, L; Mark, KE; Zhu, J; Selke, S; Magaret, A; Wald, A; Corey, L
Science Translational Medicine, 1(7): -.
ARTN 7ra16
CrossRef
Annals of Tropical Medicine and Parasitology
Human immunodeficiency virus (HIV) in developing countries
French, N; Kaleebu, P; Pisani, E; Whitworth, JAG
Annals of Tropical Medicine and Parasitology, 100(): 433-454.
10.1179/136485906X97390
CrossRef
AIDS
Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial
Ouedraogo, A; Nagot, N; Vergne, L; Konate, I; Weiss, HA; Defer, MC; Foulongne, V; Sanon, A; Andonaba, JB; Segondy, M; Mayaud, P; Van de Perre, P
AIDS, 20(): 2305-2313.

Journal of Virology
Molecular umbrellas: a novel class of candidate topical microbicides to prevent human immunodeficiency virus and herpes simplex virus infections
Madan, RP; Mesquita, PMM; Cheshenko, N; Jing, BW; Shende, V; Guzman, E; Heald, T; Keller, MJ; Regen, SL; Shattock, RJ; Herold, BC
Journal of Virology, 81(): 7636-7646.
10.1128/JVI.02851-06
CrossRef
Autoimmunity
Regulation of dendritic cells by female sex steroids: Relevance to immunity and autoimmunity
Hughes, GC; Clark, EA
Autoimmunity, 40(6): 470-481.
10.1080/08916930701464764
CrossRef
AIDS
Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
Bollen, LJM; Whitehead, SJ; Mock, PA; Leelawiwat, W; Asavapiriyanont, S; Chalermchockchareonkit, A; Vanprapar, N; Chotpitayasunondh, T; McNicholl, JM; Tappero, JW; Shaffer, N; Chuachoowong, R
AIDS, 22(): 1169-1176.

Indian Journal of Dermatology Venereology & Leprology
Herpes simplex virus 2 infection: A risk factor for HIV infection in heterosexuals
Anuradha, K; Singh, HM; Gopal, KVT; Rao, GRR; Ramani, TV; Padmaja, J
Indian Journal of Dermatology Venereology & Leprology, 74(3): 230-233.

Bulletin of Mathematical Biology
Dynamic Modeling of Herpes Simplex Virus Type-2 (HSV-2) Transmission: Issues in Structural Uncertainty
Foss, AM; Vickerman, PT; Chalabi, Z; Mayaud, P; Alary, M; Watts, CH
Bulletin of Mathematical Biology, 71(3): 720-749.
10.1007/s11538-008-9379-1
CrossRef
International Journal of Std & AIDS
Herpes simplex virus type 2 and HIV infection among US military personnel: implications for health prevention programmes
Bautista, CT; Singer, DE; O'Connell, RJ; Crum-Cianflone, N; Agan, BK; Malia, JA; Sanchez, JL; Peel, SA; Michael, NL; Scott, PT
International Journal of Std & AIDS, 20(9): 634-637.
10.1258/ijsa.2008.008413
CrossRef
Postepy Dermatologii I Alergologii
Genital ulcer diseases as an entry for HIV infection
Dus, M; Luczkowska, M; Zaba, R
Postepy Dermatologii I Alergologii, 26(4): 206-211.

Immunology
Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2
Long, BR; Erickson, AE; Chapman, JM; Barbour, JD; Vu, BAN; Ho, EL; Lanier, LL; Sauer, MM; Carvalho, KI; Nixon, DF; Kallas, EG
Immunology, 129(2): 186-196.
10.1111/j.1365-2567.2009.03170.x
CrossRef
Nature Reviews Microbiology
Why do we need quality-assured diagnostic tests for sexually transmitted infections?
Peeling, RW; Mabey, D; Herring, A; Hook, EW
Nature Reviews Microbiology, (): S7-S19.
10.1038/nrmicro1569
CrossRef
Sexually Transmitted Infections
Herpes simplex virus type 2: epidemiology and management options in developing countries
Paz-Bailey, G; Ramaswamy, M; Hawkes, SJ; Geretti, AM
Sexually Transmitted Infections, 83(1): 16-22.
10.1136/sti.2006.020966
CrossRef
Drugs
Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection
Lingappa, JR; Celum, C
Drugs, 67(2): 155-174.

Journal of Infectious Diseases
Stay it with flora: Maintaining vaginal health as a possible avenue for prevention of human immunodeficiency virus acquisition
Shin, LY; Kaul, R
Journal of Infectious Diseases, 197(): 1355-1357.
10.1086/587491
CrossRef
Virology
Replication-defective virus vaccine-induced protection of mice from genital herpes simplex virus 2 requires CD4 T cells
Morrison, LA
Virology, 376(1): 205-210.
10.1016/j.virol.2008.03.010
CrossRef
Enfermedades Infecciosas Y Microbiologia Clinica
Treatment of opportunistic infections in adolescent and adult patients infected by the human immunodeficiency virus during the era of highly active antiretroviral therapy - AIDS Study Group (GESIDA) and National AIDS Plan Expert Committe
Podzamczer, D
Enfermedades Infecciosas Y Microbiologia Clinica, 26(6): 356-379.

Journal of Virology
Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism
Fakioglu, E; Wilson, SS; Mesquita, PMM; Hazrati, E; Cheshenko, N; Blaho, JA; Herold, BC
Journal of Virology, 82(): 9337-9344.
10.1128/JVI.00603-08
CrossRef
Acta Microbiologica Et Immunologica Hungarica
Seroprevalence of Hsv-2 in Hungary and Comparison of the Hsv-2 Prevalence of Pregnant and Infertile Women
Hettmann, A; Gerle, B; Barcsay, E; Csiszar, C; Takacs, M
Acta Microbiologica Et Immunologica Hungarica, 55(4): 429-436.
10.1556/AMicr.55.2008.4.7
CrossRef
Jaids-Journal of Acquired Immune Deficiency Syndromes
High Rates of STD and Sexual Risk Behaviors Among Garifunas in Honduras
Paz-Bailey, G; Morales-Miranda, S; Jacobson, JO; Gupta, SK; Sabin, K; Mendoza, S; Paredes, M; Alvarez, B; Monterroso, E
Jaids-Journal of Acquired Immune Deficiency Syndromes, 51(): S26-S34.

Journal Der Deutschen Dermatologischen Gesellschaft
Skin diseases and sexually transmitted diseases in HIV-infected patients on HAART compared to a non-infected population - results of a retrospective study
Rothengatter, S; Sehr, T; Gholam, P; Durani, H; Hartmann, M
Journal Der Deutschen Dermatologischen Gesellschaft, 7(6): 527-532.
10.1111/j.1610-0387.2008.07001.x
CrossRef
Pediatrics
Prevalence of Sexually Transmitted Infections Among Female Adolescents Aged 14 to 19 in the United States
Forhan, SE; Gottlieb, SL; Sternberg, MR; Xu, FJ; Datta, SD; McQuillan, GM; Berman, SM; Markowitz, LE
Pediatrics, 124(6): 1505-1512.
10.1542/peds.2009-0674
CrossRef
Human Reproduction
Human immunodeficiency virus serodiscordant couples on highly active antiretroviral therapies with undetectable viral load: conception by unprotected sexual intercourse or by assisted reproduction techniques?
Vandermaelen, A; Englert, Y
Human Reproduction, 25(2): 374-379.
10.1093/humrep/dep412
CrossRef
Sexually Transmitted Infections
Interim modelling analysis to validate reported increases in condom use and assess HIV infections averted among female sex workers and clients in southern India following a targeted HIV prevention programme
Pickles, M; Foss, AM; Vickerman, P; Deering, K; Verma, S; Demers, E; Washington, R; Ramesh, BM; Moses, S; Blanchard, J; Lowndes, CM; Alary, M; Reza-Paul, S; Boily, MC
Sexually Transmitted Infections, 86(): I33-I43.
10.1136/sti.2009.038950
CrossRef
Carbohydrate Polymers
Structure of rhamnan sulfate from the green alga Monostroma nitidum and its anti-herpetic effect
Lee, JB; Koizumi, S; Hayashi, K; Hayashi, T
Carbohydrate Polymers, 81(3): 572-577.
10.1016/j.carbpol.2010.03.014
CrossRef
Substance Use & Misuse
Behavior change and health-related interventions for heterosexual risk reduction among drug users
Semaan, S; Jarlais, DCD; Malow, R
Substance Use & Misuse, 41(): 1349-1378.
10.1080/10826080600838018
CrossRef
Lancet
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial
Gray, RH; Kigozi, G; Serwadda, D; Makumbi, F; Watya, S; Nalugoda, F; Kiwanuka, N; Moulton, LH; Chaudhary, MA; Chen, MZ; Sewankambo, NK; Wabwire-Mangen, F; Bacon, MC; Williams, CFM; Opendi, P; Reynolds, SJ; Laeyendecker, O; Quinn, TC; Wawer, MJ
Lancet, 369(): 657-666.

AIDS
Response to Brown et al., 'incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe'
Williams, BG; Gouws, E; Ramjee, G; Karim, SA
AIDS, 21(): 2356-2357.

New England Journal of Medicine
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania
Watson-Jones, D; Weiss, HA; Rusizoka, M; Changalucha, J; Baisley, K; Mugeye, K; Tanton, C; Ross, D; Everett, D; Clayton, T; Balira, R; Knight, L; Hambleton, I; Le Goff, J; Belec, L; Hayes, R
New England Journal of Medicine, 358(): 1560-1571.

International Reviews of Immunology
Mucosal Immunity and Protection Against HIV/SIV Infection: Strategies and Challenges for Vaccine Design
Demberg, T; Robert-Guroff, M
International Reviews of Immunology, 28(): 20-48.
10.1080/08830180802684331
CrossRef
Sexually Transmitted Infections
Evaluation of multiplex real-time PCR for detection of Haemophilus ducreyi, Treponema pallidum, herpes simplex virus type 1 and 2 in the diagnosis of genital ulcer disease in the Rakai District, Uganda
Suntoke, TR; Hardick, A; Tobian, AAR; Mpoza, B; Laeyendecker, O; Serwadda, D; Opendi, P; Gaydos, CA; Gray, RH; Wawer, MJ; Quinn, TC; Reynolds, SJ
Sexually Transmitted Infections, 85(2): 97-101.
10.1136/sti.2008.034207
CrossRef
Expert Review of Anti-Infective Therapy
Novel approaches in fighting herpes simplex virus infections
Wilson, SS; Fakioglu, E; Herold, BC
Expert Review of Anti-Infective Therapy, 7(5): 559-568.
10.1586/ERI.09.34
CrossRef
Journal of Family Planning and Reproductive Health Care
Aspects of herpes simplex virus: a clinical review
Azwa, A; Barton, SE
Journal of Family Planning and Reproductive Health Care, 35(4): 237-242.

Plos One
Sexually Transmitted Infections among HIV-1-Discordant Couples
Guthrie, BL; Kiarie, JN; Morrison, S; John-Stewart, GC; Kinuthia, J; Whittington, WLH; Farquhar, C
Plos One, 4(): -.
ARTN e8276
CrossRef
Expert Review of Anti-Infective Therapy
Male circumcision for HIV prevention: developments from sub-Saharan Africa
de Bruyn, G; Martinson, NA; Gray, GE
Expert Review of Anti-Infective Therapy, 8(1): 23-31.
10.1586/ERI.09.120
CrossRef
Journal of Virology
Mucosal Innate and Adaptive Immune Responses against Herpes Simplex Virus Type 2 in a Humanized Mouse Model
Kwant-Mitchell, A; Ashkar, AA; Rosenthal, KL
Journal of Virology, 83(): 10664-10676.
10.1128/JVI.02584-08
CrossRef
Current Hiv Research
Relative HIV Resistance in Kenyan Sex Workers is Not Due to an Altered Prevalence or Mucosal Immune Impact of Herpes Simplex Virus Type 2 Infection
Baltzer, H; Chege, D; Rebbapragada, A; Wachihi, C; Shin, LYY; Kimani, J; Ball, TB; Jaoko, W; Plummer, FA; Kaul, R
Current Hiv Research, 7(5): 504-507.

Current Opinion in Molecular Therapeutics
siRNA-based topical microbicides targeting sexually transmitted infections
Katakowski, JA; Palliser, D
Current Opinion in Molecular Therapeutics, 12(2): 192-202.

Lancet
Sexual and reproductive health 5 - Global control of sexually transmitted infections
Low, N; Broutet, N; Adu-Sarkodie, Y; Barton, P; Hossain, M; Hawkes, S
Lancet, 368(): 2001-2016.
10.1016/S0140-6736(06)69482-8
CrossRef
Lancet
Genital herpes
Gupta, R; Warren, T; Wald, A
Lancet, 370(): 2127-2137.

Mucosal Immunology
Differences in immunoregulatory cytokine expression patterns in the systemic and genital tract compartments of HIV-1-infected commercial sex workers in Benin
Lajoie, J; Poudrier, J; Massinga-Loembe, M; Guedou, F; Agossa-Gbenafa, C; Labbe, AC; Alary, M; Roger, M
Mucosal Immunology, 1(4): 309-316.
10.1038/mi.2008.18
CrossRef
Antimicrobial Agents and Chemotherapy
Amphipathic DNA polymers exhibit antiherpetic activity in vitro and in vivo
Bernstein, DI; Goyette, N; Cardin, R; Kern, ER; Boivin, G; Ireland, J; Juteau, JM; Vaillant, A
Antimicrobial Agents and Chemotherapy, 52(8): 2727-2733.
10.1128/AAC.00279-08
CrossRef
Sexually Transmitted Infections
Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women
Mayaud, P; Nagot, N; Konate, I; Ouedraogo, A; Weiss, HA; Foulongne, V; Defer, MC; Sawadogo, A; Segondy, M; de Perre, PV
Sexually Transmitted Infections, 84(5): 332-337.
10.1136/sti.2008.030692
CrossRef
Sexually Transmitted Infections
Screening for genital and anorectal sexually transmitted infections in HIV prevention trials in Africa
Grijsen, ML; Graham, SM; Mwangome, M; Githua, P; Mutimba, S; Wamuyu, L; Okuku, H; Price, MA; McClelland, RS; Smith, AD; Sanders, EJ
Sexually Transmitted Infections, 84(5): 364-370.
10.1136/sti.2007.028852
CrossRef
Cell Host & Microbe
Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues
Lisco, A; Vanpouille, C; Tchesnokov, EP; Grivel, JC; Biancotto, A; Brichacek, B; Elliott, J; Fromentin, E; Shattock, R; Anton, P; Gorelick, R; Balzarini, J; McGuigan, C; Derudas, M; Gotte, M; Schinazi, RF; Margolis, L
Cell Host & Microbe, 4(3): 260-270.
10.1016/j.chom.2008.07.008
CrossRef
Expert Review of Anti-Infective Therapy
Aciclovir, herpes viruses and HIV: a never-ending story
Volpi, A; Sarrecchia, C; Sordillo, P
Expert Review of Anti-Infective Therapy, 7(4): 403-407.
10.1586/ERI.09.21
CrossRef
International Journal of Std & AIDS
Aetiology of genital ulcer disease in female partners of male participants in a circumcision trial in Uganda
Brankin, AE; Tobian, AAR; Laeyendecker, O; Suntoke, TR; Kizza, A; Mpoza, B; Kigozi, G; Nalugoda, F; Iga, B; Chen, MZ; Gray, RH; Wawer, MJ; Quinn, TC; Reynolds, SJ
International Journal of Std & AIDS, 20(9): 650-651.
10.1258/ijsa.2009.009067
CrossRef
Vaccine
Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa
Freeman, EE; White, RG; Bakker, R; Orroth, KK; Weiss, HA; Buve, A; Hayes, RJ; Glynn, JR
Vaccine, 27(6): 940-946.
10.1016/j.vaccine.2008.11.074
CrossRef
AIDS Care-Psychological and Socio-Medical Aspects of AIDS/Hiv
Discussion and revision of the mathematical modeling tool described in the previously published article "Modeling HIV Transmission risk among Mozambicans prior to their initiating highly active antiretroviral therapy"
Cassels, S; Pearson, CR; Kurth, AE; Martin, DP; Simoni, JM; Matediana, E; Gloyd, S
AIDS Care-Psychological and Socio-Medical Aspects of AIDS/Hiv, 21(7): 858-862.
10.1080/09540120802626204
CrossRef
Journal of Immunology
Herpes Simplex Virus Infects Skin gamma delta T Cells before Langerhans Cells and Impedes Migration of Infected Langerhans Cells by Inducing Apoptosis and Blocking E-Cadherin Downregulation
Puttur, FK; Fernandez, MA; White, R; Roediger, B; Cunningham, AL; Weninger, W; Jones, CA
Journal of Immunology, 185(1): 477-487.
10.4049/jimmunol.0904106
CrossRef
Journal of Infectious Diseases
New information on the risks of HIV transmission in Mwanza, Tanzania - Reply to Gisselquist
Todd, J; Grosskurth, H; Hayes, R
Journal of Infectious Diseases, 194(4): 537-538.

Bmc Public Health
Prevalence of HIV, Herpes Simplex Virus-2, and Syphilis in male sex partners of pregnant women in Peru
Clark, JL; Konda, KA; Munayco, CV; Pun, M; Lescano, AG; Leon, SR; Pajuelo, J; Suarez-Ognio, L; Klausner, JD; Coates, TJ; Caceres, CF
Bmc Public Health, 8(): -.
ARTN 65
CrossRef
Lancet
Reassessing the hypothesis on STI control for HIV prevention
Gray, RH; Wawer, MJ
Lancet, 371(): 2064-2065.

Sexually Transmitted Infections
Proportion of new HIV infections attributable to herpes simplex 2 increases over time: simulations of the changing role of sexually transmitted infections in sub-Saharan African HIV epidemics
Freeman, EE; Orroth, KK; White, RG; Glynn, JR; Bakker, R; Boily, MC; Habbema, D; Buve, A; Hayes, RJ
Sexually Transmitted Infections, 83(): I17-I24.
10.1136/sti.2006.023549
CrossRef
Sexually Transmitted Infections
Relative prevalence of different sexually transmitted infections in HIV-discordant sexual partnerships: data from a risk network study in a high-risk New York neighbourhood
Friedman, SR; Bolyard, M; Sandoval, M; Mateu-Gelabert, P; Maslow, C; Zenilman, J
Sexually Transmitted Infections, 84(1): 17-18.
10.1136/sti.2007.026815
CrossRef
Journal of Reproductive Immunology
The genital tract immune milieu: An important determinant of HIV susceptibility and secondary transmission
Kaul, R; Pettengell, C; Sheth, PM; Sunderji, S; Biringer, A; MacDonald, K; Walmsey, S; Rebbapragada, A
Journal of Reproductive Immunology, 77(1): 32-40.
10.1016/j.jri.2007.02.002
CrossRef
Lancet
Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial
Celum, C; Wald, A; Hughes, J; Sanchez, J; Reid, S; Delany-Moretlwe, S; Cowan, F; Casapia, M; Ortiz, A; Fuchs, J; Buchbinder, S; Koblin, B; Zwerski, S; Rose, S; Wang, J; Corey, L
Lancet, 371(): 2109-2119.

Postgraduate Medical Journal
Herpes simplex virus type 2: epidemiology and management options in developing countries
Paz-Bailey, G; Ramaswamy, M; Hawkes, SJ; Geretti, AM
Postgraduate Medical Journal, 84(): 299-306.
10.1136/sti.2006.020966
CrossRef
Ginekologia Polska
Pathogenesis and risk of HIV infection in women - review of recent literature
Tomasz, N; Dorota, RS; Anna, W; Asmaa, E
Ginekologia Polska, 80(1): 41-46.

Infectious Disease Clinics of North America
Identifying Risk Factors for Infections: The Role of Meta-analyses
Tacconelli, E; Cataldo, MA
Infectious Disease Clinics of North America, 23(2): 211-+.
10.1016/j.idc.2009.01.011
CrossRef
Journal of Infectious Diseases
Improvement in Healing and Reduction in HIV Shedding with Episodic Acyclovir Therapy as Part of Syndromic Management among Men: A Randomized, Controlled Trial
Paz-Bailey, G; Sternberg, M; Puren, AJ; Markowitz, LE; Ballard, R; Delany, S; Hawkes, S; Nwanyanwu, O; Ryan, C; Lewis, DA
Journal of Infectious Diseases, 200(7): 1039-1049.
10.1086/605647
CrossRef
AIDS and Behavior
Poverty, Sex and HIV
Nattrass, N
AIDS and Behavior, 13(5): 833-840.
10.1007/s10461-009-9563-9
CrossRef
Sexually Transmitted Infections
Ecological analysis of the association between high-risk population parameters and HIV prevalence among pregnant women enrolled in sentinel surveillance in four southern India states
Alary, M; Jayachandran, AA; Lowndes, CM; Bradley, J; Demers, E; Adhikary, R; Mainkar, MK
Sexually Transmitted Infections, 86(): I10-I16.
10.1136/sti.2009.038323
CrossRef
Journal of Infectious Diseases
Increased Risk of HIV Acquisition among Kenyan Men with Human Papillomavirus Infection
Smith, JS; Moses, S; Hudgens, MG; Parker, CB; Agot, K; Maclean, I; Ndinya-Achola, JO; Snijders, PJF; Meijer, CJLM; Bailey, RC
Journal of Infectious Diseases, 201(): 1677-1685.
10.1086/652408
CrossRef
New England Journal of Medicine
Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2 REPLY
Celum, C; Lingappa, JR; Wald, A
New England Journal of Medicine, 362(): 1741-1742.

British Medical Journal
Contribution of problem drug users' deaths to excess mortality in Scotland: secondary analysis of cohort study
Bloor, M; Gannon, M; Hay, G; Jackson, G; Leyland, AH; McKeganey, N
British Medical Journal, 337(): -.
ARTN a478
CrossRef
Sexually Transmitted Infections
Herpes complex
Rietmeijer, CA; Low, N
Sexually Transmitted Infections, 84(5): 330-331.
10.1136/sti.2008.032003
CrossRef
Sexually Transmitted Infections
Herpes simplex virus type 2 trends in relation to the HIV epidemic in northern Malawi
Glynn, JR; Crampin, AC; Ngwira, BMM; Ndhlovu, R; Mwanyongo, O; Fine, PEM
Sexually Transmitted Infections, 84(5): 356-360.
10.1136/sti.2008.030056
CrossRef
Expert Review of Vaccines
STEP trial and HIV-1 vaccines inducing T-cell responses
Hanke, T
Expert Review of Vaccines, 7(3): 303-309.
10.1586/14760584.7.3.303
CrossRef
AIDS
Vulnerability of women in southern Africa to infection with HIV: biological determinants and priority health sector interventions
Chersich, MF; Rees, HV
AIDS, 22(): S27-S40.

Journal of Clinical Virology
Serologic detection of herpes simplex virus type 2 antibodies among pregnant women using a point-of-care test from Focus Diagnostics
Leyland, B; Kennedy, MR; Wimberly, YH; Levine, BJ; Cherpes, TL
Journal of Clinical Virology, 44(2): 125-128.
10.1016/j.jcv.2008.11.009
CrossRef
Journal of Infectious Diseases
Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection
Cachay, ER; Frost, SDW; Richman, DD; Smith, DM; Little, SJ
Journal of Infectious Diseases, 195(9): 1270-1277.
10.1086/513568
CrossRef
Sexually Transmitted Infections
Risk of herpes simplex virus type 2 acquisition increases over early adulthood: evidence from a cohort study
Dickson, N; van Roode, T; Herbison, P; Taylor, J; Cunningham, A; Paul, C
Sexually Transmitted Infections, 83(2): 87-90.
10.1136/sti.2006.020883
CrossRef
Sexually Transmitted Infections
Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies
Nagot, N; Ouedraogo, A; Defer, MC; Vallo, R; Mayaud, P; de Perre, PV
Sexually Transmitted Infections, 83(5): 365-368.
10.1136/sti.2007.024794
CrossRef
Canadian Journal of Infectious Diseases & Medical Microbiology
The diagnosis of genital herpes - beyond culture: An evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology
Ratnam, S; Severini, A; Zahariadis, C; Petric, M; Romanwski, B
Canadian Journal of Infectious Diseases & Medical Microbiology, 18(4): 233-240.

Expert Opinion on Emerging Drugs
The potential impact of a prophylactic herpes simplex vaccine
Rupp, R; Bernstein, DI
Expert Opinion on Emerging Drugs, 13(1): 41-52.
10.1517/14728214.13.1.41
CrossRef
International Journal of Std & AIDS
Low seroprevalence of herpes simplex virus type 2 among pregnant women in Senegal
Diawara, S; Kane, CT; Legoff, J; Gaye, AG; Mboup, S; Belec, L
International Journal of Std & AIDS, 19(3): 159-160.
10.1258/ijsa.2007.007139
CrossRef
Drug and Alcohol Dependence
The associations of binge alcohol use with HIV/STI risk and diagnosis among heterosexual African American men
Raj, A; Reed, E; Santana, MC; Walley, AY; Welles, SL; Horsburgh, CR; Flores, SA; Silverman, JG
Drug and Alcohol Dependence, 101(): 101-106.
10.1016/j.drugalcdep.2008.11.008
CrossRef
Bmc Infectious Diseases
Seroprevalence and factors associated with herpes simplex virus type 2 among HIV-negative high-risk men who have sex with men from Rio de Janeiro, Brazil: a cross-sectional study
Rodrigues, J; Grinsztejn, B; Bastos, FI; Velasque, L; Luz, PM; de Souza, CT; Georg, I; Pilotto, JH; Veloso, VG
Bmc Infectious Diseases, 9(): -.
ARTN 39
CrossRef
Clinical Infectious Diseases
Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings
Vlahov, D; Robertson, AM; Strathdee, SA
Clinical Infectious Diseases, 50(): S114-S121.
10.1086/651482
CrossRef
Mayo Clinic Proceedings
Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: A US-based randomized, double-blind, placebo-controlled clinical trial
Fife, KH; Warren, TJ; Ferrera, RD; Young, DG; Justus, SE; Heitman, CK; Burroughs, SM
Mayo Clinic Proceedings, 81(): 1321-1327.

Journal of Infectious Diseases
Predictors of Herpes simplex virus type 2 prevalence and incidence among bar and hotel workers in Moshi, Tanzania
Tassiopoulos, KK; Seage, G; Sam, N; Kiwelu, I; Shao, J; Ao, TTH; Essex, M; Coplan, P; Rosenberg, Z; Hughes, M; Kapiga, S
Journal of Infectious Diseases, 195(4): 493-501.

Journal of Infectious Diseases
Herpes simplex virus type 2 and HIV-1: The dialogue between the 2 organisms continues
Corey, L
Journal of Infectious Diseases, 195(9): 1242-1244.
10.1086/513570
CrossRef
Journal of Infectious Diseases
Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels
Nagot, N; Ouedraogo, A; Konate, I; Weiss, HA; Foulongne, V; Defer, MC; Sanon, A; Becquart, P; Segondy, M; Sawadogo, A; Van de Perre, P; Mayaud, P
Journal of Infectious Diseases, 198(2): 241-249.
10.1086/589621
CrossRef
British Medical Journal
Impact of Stepping Stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial
Jewkes, R; Nduna, M; Levin, J; Jama, N; Dunkle, K; Puren, A; Duvvury, N
British Medical Journal, 337(): -.
ARTN a506
CrossRef
Mucosal Immunology
Dendritic cells and macrophages in the genitourinary tract
Iijima, N; Thompson, JM; Iwasaki, A
Mucosal Immunology, 1(6): 451-459.
10.1038/mi.2008.57
CrossRef
Journal of American College Health
Serologic Screening for Herpes Simplex Virus Among University Students: A Pilot Study
Mark, H; Nanda, JP; Joffe, A; Roberts, J; Rompalo, A; Melendez, J; Zenilman, J
Journal of American College Health, 56(3): 291-296.

Plos One
Genital Herpes Has Played a More Important Role than Any Other Sexually Transmitted Infection in Driving HIV Prevalence in Africa
Abu-Raddad, LJ; Magaret, AS; Celum, C; Wald, A; Longini, IM; Self, SG; Corey, L
Plos One, 3(5): -.
ARTN e2230
CrossRef
Infections in Medicine
Sexually Transmitted Viral Infections in Women: HIV, HSV, and HPV
Morrison, EAB
Infections in Medicine, 26(1): 13-17.

Sexually Transmitted Infections
Population-level effect of HSV-2 therapy on the incidence of HIV in sub-Saharan Africa
White, RG; Freeman, EE; Orroth, KK; Bakker, R; Weiss, HA; O'Farrell, N; Buve, A; Hayes, RJ; Glynn, JR
Sexually Transmitted Infections, 84(): II12-II18.
10.1136/sti.2008.029918
CrossRef
Journal of Biological Chemistry
The Antiherpetic Drug Acyclovir Inhibits HIV Replication and Selects the V75I Reverse Transcriptase Multidrug Resistance Mutation
McMahon, MA; Siliciano, JD; Lai, J; Liu, JO; Stivers, JT; Siliciano, RF; Kohli, RM
Journal of Biological Chemistry, 283(): 31289-31293.
10.1074/jbc.C800188200
CrossRef
Plos One
HIV Prevalence and Associated Risk Factors among Individuals Aged 13-34 Years in Rural Western Kenya
Amornkul, PN; Vandenhoudt, H; Nasokho, P; Odhiambo, F; Mwaengo, D; Hightower, A; Buve, A; Misore, A; Vulule, J; Vitek, C; Glynn, J; Greenberg, A; Slutsker, L; De Cock, KM
Plos One, 4(7): -.
ARTN e6470
CrossRef
Sexual Health
Risk factors for herpes simplex virus type 2 and its association with HIV among pregnant teenagers in Zimbabwe
Munjoma, MW; Mapingure, MP; Stray-Pedersen, B
Sexual Health, 7(1): 87-89.
10.1071/SH09106
CrossRef
Lancet
Genital herpes in Africa: time to rethink treatment
O'Farrell, N; Moodley, P; Sturm, AW
Lancet, 370(): 2164-2166.

Journal of Infectious Diseases
Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation
Sheth, PM; Sunderji, S; Shin, LYY; Rebbapragada, A; Huibner, S; Kimani, J; MacDonald, KS; Ngugi, E; Bwayo, JJ; Moses, S; Kovacs, C; Loutfy, M; Kaul, R
Journal of Infectious Diseases, 197(): 1394-1401.
10.1086/587697
CrossRef
Bmc Infectious Diseases
Seroepidemiology of viral hepatitis, HIV and herpes simplex type 2 in the household population aged 21-64 years in Puerto Rico
Perez, CM; Marrero, E; Melendez, M; Adrovet, S; Colon, H; Ortiz, AP; Soto-Salgado, M; Albizu, C; Torres, EA; Suarez, E
Bmc Infectious Diseases, 10(): -.
ARTN 76
CrossRef
International Journal of Antimicrobial Agents
Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseria gonorrhoeae
Chu, H; Slepenkin, A; Elofsson, M; Keyser, P; de la Maza, LM; Peterson, EM
International Journal of Antimicrobial Agents, 36(2): 145-150.
10.1016/j.ijantimicag.2010.03.018
CrossRef
American Journal of Reproductive Immunology
Impact of microbicides and sexually transmitted infections on mucosal immunity in the female genital tract
Keller, MJ; Herold, BC
American Journal of Reproductive Immunology, 56(): 356-363.
10.1111/j.1600-0897.2006.00436.x
CrossRef
Journal of Infectious Diseases
Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru
Lama, JR; Lucchetti, A; Suarez, L; Laguna-Torres, VA; Guanira, JV; Pun, M; Montano, SM; Celum, CL; Carr, JK; Sanchez, J; Bautista, CT; Sanchez, JL
Journal of Infectious Diseases, 194(): 1459-1466.

Journal of Infectious Diseases
The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania
Kapiga, SH; Sam, NE; Bang, H; Ni, QH; Ao, TTH; Kiwelu, I; Chiduo, S; Ndibe, U; Seage, G; Coplan, P; Shao, J; Rosenberg, ZF; Essex, M
Journal of Infectious Diseases, 195(9): 1260-1269.
10.1086/513566
CrossRef
AIDS
Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women
Baeten, JM; Benki, S; Chohan, V; Lavreys, L; McClelland, RS; Mandaliya, K; Ndinya-Achola, JO; Jaoko, W; Overbaugh, J
AIDS, 21(): 1771-1777.

Sexually Transmitted Infections
Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing
Smith, JS; Bailey, RC; Westreich, DJ; Maclean, I; Agot, K; Ndinya-Achola, JO; Hogrefe, W; Morrow, RA; Moses, S
Sexually Transmitted Infections, 85(2): 92-96.
10.1136/sti.2008.031815
CrossRef
Nature Medicine
Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition
Zhu, J; Hladik, F; Woodward, A; Klock, A; Peng, T; Johnston, C; Remington, M; Magaret, A; Koelle, DM; Wald, A; Corey, L
Nature Medicine, 15(8): 886-U83.
10.1038/nm.2006
CrossRef
AIDS Reviews
HIV Incidence in Sub-Saharan Africa: A Review of Available Data with Implications for Surveillance and Prevention Planning
Braunstein, SL; van de Wijgert, JHHM; Nash, D
AIDS Reviews, 11(3): 140-156.

Virology Journal
FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection
Rose, WA; McGowin, CL; Pyles, RB
Virology Journal, 6(): -.
ARTN 195
CrossRef
Plos One
A Macaque Model to Study Vaginal HSV-2/Immunodeficiency Virus Co-Infection and the Impact of HSV-2 on Microbicide Efficacy
Crostarosa, F; Aravantinou, M; Akpogheneta, OJ; Jasny, E; Shaw, A; Kenney, J; Piatak, M; Lifson, JD; Teitelbaum, A; Hu, LY; Chudolij, A; Zydowsky, TM; Blanchard, J; Gettie, A; Robbiani, M
Plos One, 4(): -.
ARTN e8060
CrossRef
Tropical Medicine & International Health
Do behavioural differences help to explain variations in HIV prevalence in adolescents in sub-Saharan Africa?
Chapman, R; White, RG; Shafer, LA; Pettifor, A; Mugurungi, O; Ross, D; Pascoe, S; Cowan, FM; Grosskurth, H; Buve, A; Hayes, RJ
Tropical Medicine & International Health, 15(5): 554-566.
10.1111/j.1365-3156.2010.02483.x
CrossRef
Journal of Infectious Diseases
Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections
Kaul, R; Nagelkerke, NJ; Kimani, J; Ngugi, E; Bwayo, JJ; MacDonald, KS; Rebbaprgada, A; Fonck, K; Temmerman, M; Ronald, AR; Moses, S
Journal of Infectious Diseases, 196(): 1692-1697.
10.1086/522006
CrossRef
Virology
Disruption of the U(L)41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpes
Dudek, T; Mathews, LC; Knipe, DM
Virology, 372(1): 165-175.
10.1016/j.virol.2007.10.014
CrossRef
Annual Review of Medicine
Herpes simplex: Insights on pathogenesis and possible vaccines
Koelle, DM; Corey, L
Annual Review of Medicine, 59(): 381-395.
10.1146/annurev.med.59.061606.095540
CrossRef
Sexually Transmitted Infections
Modelling the cost per ulcer treated of incorporating episodic treatment for HSV-2 into the syndromic algorithm for genital ulcer disease
Vickerman, P; Ndowa, F; Mayaud, P
Sexually Transmitted Infections, 84(3): 243-248.
10.1136/sti.2007.027136
CrossRef
Lancet
HIV prevention 2 - Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward
Padian, NS; Buve, A; Balkus, J; Serwadda, D; Cates, W
Lancet, 372(): 585-599.
10.1016/S0140-6736(08)60885-5
CrossRef
Drug and Alcohol Dependence
Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City
Jarlais, DCD; Arasteh, K; McKnight, C; Hagan, H; Perlman, D; Friedman, SR
Drug and Alcohol Dependence, 101(): 88-91.
10.1016/j.drugalcdep.2008.11.007
CrossRef
Future Virology
Off-label indication: acyclovir as an anti-HIV drug?
Vanpouille, C; Lisco, A; Margolis, L
Future Virology, 4(1): 1-5.
10.2217/17460794.4.1.1
CrossRef
Journal of Epidemiology and Community Health
HIV prevention and psychoactive drug use: a research agenda
Jarlais, DCD; Semaan, S
Journal of Epidemiology and Community Health, 63(3): 191-196.
10.1136/jech.2008.079301
CrossRef
International Journal of Infectious Diseases
Prevalence and predictors of HIV infection among female sex workers in Kaiyuan City, Yunnan Province, China
Wang, HB; Chen, RY; Ding, GW; Ma, YL; Ma, JG; Jiao, JH; Wo, ZL; Sharp, GB; Wang, N
International Journal of Infectious Diseases, 13(2): 162-169.
10.1016/j.ijid.2008.05.1229
CrossRef
Future Microbiology
Role of HSV-2 suppressive therapy for HIV prevention
Reynolds, SJ
Future Microbiology, 4(9): 1095-1097.
10.2217/FMB.09.81
CrossRef
Contemporary Clinical Trials
Measurement and predictors of adherence in a trial of HSV suppressive therapy in Tanzania
Watson-Jones, D; Baisley, K; Rusizoka, M; Tanton, C; Mugeye, K; Weiss, HA; Changalucha, J; Clayton, T; Hambleton, I; Ross, DA; Hayes, RJ
Contemporary Clinical Trials, 30(6): 504-512.
10.1016/j.cct.2009.07.002
CrossRef
Journal of Internal Medicine
Mucosal immune responses in the genital tract of HIV-1-exposed uninfected women
Hirbod, T; Broliden, K
Journal of Internal Medicine, 262(1): 44-58.
10.1111/j.1365-2796.2007.01822.x
CrossRef
Journal of Infectious Diseases
Transmission of herpes simplex virus types 1 and 2 in a prospective cohort of HIV negative gay men: The Health in Men Study
Jin, FY; Prestage, GP; Mao, LM; Kippax, SC; Pell, CM; Donovan, B; Templeton, DJ; Taylor, J; Mindel, A; Kaldor, JM; Grulich, AE
Journal of Infectious Diseases, 194(5): 561-570.

Nature Reviews Microbiology
Why do we need quality-assured diagnostic tests for sexually transmitted infections?
Peeling, RW; Mabey, D; Herring, A; Hook, EW
Nature Reviews Microbiology, 4(): 909-921.
10.1038/nrmicro1555
CrossRef
Journal of Clinical Microbiology
Performance of the HerpeSelect (Focus) and kalon enzyme-linked immunosorbent assays for detection of antibodies against herpes simplex virus type 2 by use of monoclonal antibody-blocking enzyme immunoassay and clinicovirological reference standards in Brazil
Nascimento, MC; Ferreira, S; Sabino, E; Hamilton, I; Parry, J; Pannuti, CS; Mayaud, P
Journal of Clinical Microbiology, 45(7): 2309-2311.
10.1128/JCM.00144-07
CrossRef
Human Vaccines
Effectiveness and efficiency of imperfect therapeutic HSV-2 vaccines
Schwartz, EJ; Bodine, EN; Blower, S
Human Vaccines, 3(6): 231-238.

Presse Medicale
Herpes serology for genital herpes
Legoff, J; Aymard, M; Braig, S; Ramel, F; Dreno, B; Belec, L; Malkin, JE
Presse Medicale, 37(9): 1251-1260.
10.1016/j.lpm.2007.07.008
CrossRef
Journal of Infectious Diseases
Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults
Mark, KE; Wald, A; Magaret, AS; Selke, S; Olin, L; Huang, ML; Corey, L
Journal of Infectious Diseases, 198(8): 1141-1149.
10.1086/591913
CrossRef
Nature Reviews Microbiology
Chromatin control of herpes simplex virus lytic and latent infection
Knipe, DM; Cliffe, A
Nature Reviews Microbiology, 6(3): 211-221.
10.1038/nrmicro1794
CrossRef
Journal of Virology
Candidate microbicide PPCM blocks human immunodeficiency virus type 1 infection in cell and tissue cultures and prevents genital herpes in a murine model
Mesquita, PMM; Wilson, SS; Manlow, P; Fischetti, L; Keller, MJ; Herold, BC; Shattock, RJ
Journal of Virology, 82(): 6576-6584.
10.1128/JVI.00335-08
CrossRef
Bulletin of the World Health Organization
An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection
Looker, KJ; Gamett, GP; Schmid, GP
Bulletin of the World Health Organization, 86(): 805-812.
10.2471/BLT.07.046128
CrossRef
Sexually Transmitted Infections
Prospective study of correlates of vaginal Lactobacillus colonisation among high-risk HIV-1 seronegative women
Baeten, JM; Hassan, WM; Chohan, V; Richardson, BA; Mandaliya, K; Ndinya-Achola, JO; Jaoko, W; McClelland, RS
Sexually Transmitted Infections, 85(5): 348-353.
10.1136/sti.2008.035451
CrossRef
Journal of Investigative Dermatology
Vaccines and Microbicides Preventing HIV-1, HSV-2, and HPV Mucosal Transmission
Nikolic, DS; Piguet, V
Journal of Investigative Dermatology, 130(2): 352-361.
10.1038/jid.2009.227
CrossRef
Journal of Infectious Diseases
Clinical and Virologic Efficacy of Herpes Simplex Virus Type 2 Suppression by Acyclovir in a Multicontinent Clinical Trial
Fuchs, J; Celum, C; Wang, J; Hughes, J; Sanchez, J; Cowan, F; Reid, S; Delany-Moretlwe, S; Corey, L; Wald, A
Journal of Infectious Diseases, 201(8): 1164-1168.
10.1086/651381
CrossRef
Reviews in Medical Virology
Treatment of herpesvirus cofactors?
Griffiths, PD
Reviews in Medical Virology, 19(1): 1-6.
10.1002/rmv.604
CrossRef
Journal of Infectious Diseases
Circumcision's Place in the Vicious Cycle Involving Herpes Simplex Virus Type 2 and HIV
Bailey, RC; Mehta, SD
Journal of Infectious Diseases, 199(7): 923-925.
10.1086/597209
CrossRef
Plos One
Characteristics of HIV-1 Discordant Couples Enrolled in a Trial of HSV-2 Suppression to Reduce HIV-1 Transmission: The Partners Study
Lingappa, JR; Kahle, E; Mugo, N; Mujugira, A; Magaret, A; Baeten, J; Bukusi, EA; Cohen, CR; Katabira, E; Ronald, A; Kiarie, J; Farquhar, C; Stewart, GJ; Makhema, J; Essex, M; Were, E; Fife, K; deBruyn, G; Gray, G; McIntyre, J; Manongi, R; Kapiga, S; Coetzee, D; Allen, S; Inambao, M; Kayitenkore, K; Karita, E; Kanweka, W; Delany, S; Rees, H; Vwalika, B; Coombs, RW; Morrow, R; Whittington, W; Corey, L; Wald, A; Celum, C
Plos One, 4(4): -.
ARTN e5272
CrossRef
American Journal of Reproductive Immunology
Female Genital Tract Secretions Inhibit Herpes Simplex Virus Infection: Correlation with Soluble Mucosal Immune Mediators and Impact of Hormonal Contraception
Shust, GF; Cho, S; Kim, M; Madan, RP; Guzman, EM; Pollack, M; Epstein, J; Cohen, HW; Keller, MJ; Herold, BC
American Journal of Reproductive Immunology, 63(2): 110-119.
10.1111/j.1600-0897.2009.00768.x
CrossRef
Journal of Clinical Immunology
Chemokine Expression Patterns in the Systemic and Genital Tract Compartments are Associated with HIV-1 Infection in Women from Benin
Lajoie, J; Poudrier, J; Loembe, MM; Guedou, F; Leblond, F; Labbe, AC; Alary, M; Roger, M
Journal of Clinical Immunology, 30(1): 90-98.
10.1007/s10875-009-9343-3
CrossRef
AIDS and Behavior
Integrating HIV Prevention into Services for Abused Women in South Africa
Sikkema, KJ; Neufeld, SA; Hansen, NB; Mohlahlane, R; Van Rensburg, MJ; Watt, MH; Fox, AM; Crewe, M
AIDS and Behavior, 14(2): 431-439.
10.1007/s10461-009-9620-4
CrossRef
Mikrobiyoloji Bulteni
Frequency of Curable Sexually Transmitted Infections Among Registered Female Sex-Workers in Ankara City
Zarakolu, P; Alp, S; Yagci, S
Mikrobiyoloji Bulteni, 44(1): 117-121.

AIDS Care-Psychological and Socio-Medical Aspects of AIDS/Hiv
A qualitative study of participant adherence in a randomized controlled trial of herpes suppressive therapy for HIV prevention in Tanzania
Plummer, ML; Watson-Jones, D; Lees, S; Baisley, K; Matari, S; Changalucha, J; Clayton, T; Mugeye, K; Tanton, C; Weiss, HA; Ross, DA; Hayes, RJ
AIDS Care-Psychological and Socio-Medical Aspects of AIDS/Hiv, 22(4): 499-508.
10.1080/09540120903202889
CrossRef
Journal of Urology
Circumcision and Reduced Risk of Self-Reported Penile Coital Injuries: Results From a Randomized Controlled Trial in Kisumu, Kenya
Mehta, SD; Krieger, JN; Agot, K; Moses, S; Ndinya-Achola, JO; Parker, C; Bailey, RC
Journal of Urology, 184(1): 203-209.
10.1016/j.juro.2010.03.015
CrossRef
New England Journal of Medicine
Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus
Nagot, N; Ouedraogo, A; Foulongne, V; Konate, I; Weiss, HA; Vergne, L; Defer, M; Djagbare, D; Sanon, A; Andonaba, J; Becquart, P; Segondy, M; Vallo, R; Sawadogo, A; Van de Perre, P; Mayaud, P; Bahembera, E; Berthe, A; Coulibaly, M; Defer, MC; Diallo, R; Djagbare, D; Konate, I; Ky-Dama, F; M'Boutiki, GT; Meda, N; Millogo, I; Nagot, N; Ouedraogo, A; Ouedraogo, D; Rouet, F; Sanon, A; Sawadogo, H; Vallo, R; Vergne, L; Mayaud, P; Nagot, N; Weiss, HA; Becquart, P; Foulongne, V; Segondy, M; Van de Perre, P; Andonaba, JB; Sawadogo, A
New England Journal of Medicine, 356(8): 790-799.

AIDS
Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes
LeGoff, J; Weiss, HA; Gresenguet, G; Nzambi, K; Frost, E; Hayes, RJ; Mabey, DCW; Malkin, JE; Mayaud, P; Belec, L
AIDS, 21(): 1569-1578.

Lancet Infectious Diseases
Herpes simplex virus and HIV-1: deciphering viral synergy
de Perre, PV; Segondy, M; Foulongne, V; Ouedraogo, A; Konate, I; Huraux, JM; Mayaud, P; Nagot, N
Lancet Infectious Diseases, 8(8): 490-497.

AIDS Care-Psychological and Socio-Medical Aspects of AIDS/Hiv
Modeling HIV transmission risk among Mozambicans prior to their initiating highly active antiretroviral therapy
Pearson, CR; Kurth, AE; Cassels, S; Martin, DP; Simoni, JM; Hoff, P; Matediana, E; Gloyd, S
AIDS Care-Psychological and Socio-Medical Aspects of AIDS/Hiv, 19(5): 594-604.
10.1080/09540120701203337
CrossRef
Clinical Infectious Diseases
The influence of hormonal contraceptive use on HIV-1 transmission and disease progression
Baeten, JM; Lavreys, L; Overbaugh, J
Clinical Infectious Diseases, 45(3): 360-369.
10.1086/519432
CrossRef
Expert Review of Anti-Infective Therapy
Interactions and management issues in HSV and HIV coinfection
Ramaswamy, M; Geretti, AM
Expert Review of Anti-Infective Therapy, 5(2): 231-243.
10.1586/14787210.5.2.231
CrossRef
Virology
Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular disease
van Lint, AL; Torres-Lopez, E; Knipe, DM
Virology, 368(2): 227-231.
10.1016/j.virol.2007.08.030
CrossRef
Sexually Transmitted Infections
High-risk sexual behaviour in men attending a sexually transmitted infection clinic in Durban, South Africa
O'Farrell, N; Morison, L; Moodley, P; Pillay, K; Vanmali, T; Quigley, M; Sturm, AW
Sexually Transmitted Infections, 83(7): 530-533.
10.1136/sti.2007.026716
CrossRef
Antiviral Research
Sexual transmission of HIV-1
Fox, J; Fidler, S
Antiviral Research, 85(1): 276-285.
10.1016/j.antiviral.2009.10.012
CrossRef
AIDS Research and Human Retroviruses
HSV Type 2 Infection Increases HIV DNA Detection in Vaginal Tissue of Mice Expressing Human CD4 and CCR5
Zariffard, MR; Saifuddin, M; Finnegan, A; Spear, GT
AIDS Research and Human Retroviruses, 25(): 1157-1164.
10.1089/aid.2009.0035
CrossRef
Journal of Infectious Diseases
A New Class of Dual-Targeted Antivirals: Monophosphorylated Acyclovir Prodrug Derivatives Suppress Both Human Immunodeficiency Virus Type 1 and Herpes Simplex Virus Type 2
Vanpouille, C; Lisco, A; Derudas, M; Saba, E; Grivel, JC; Brichacek, B; Scrimieri, F; Schinazi, R; Schols, D; McGuigan, C; Balzarini, J; Margolis, L
Journal of Infectious Diseases, 201(4): 635-643.
10.1086/650343
CrossRef
Clinical Infectious Diseases
Treatment to Prevent Transmission of HIV-1
Cohen, MS; Gay, CL
Clinical Infectious Diseases, 50(): S85-S95.
10.1086/651478
CrossRef
American Journal of Reproductive Immunology
HIV Infection in the Female Genital Tract: Discrete Influence of the Local Mucosal Microenvironment
Kaushic, C; Ferreira, VH; Kafka, JK; Nazli, A
American Journal of Reproductive Immunology, 63(6): 566-575.
10.1111/j.1600-0897.2010.00843.x
CrossRef
Current Medical Research and Opinion
Single-day famciclovir therapy for recurrent genital herpes
Whitley, R; Diaz-Mitoma, F; Hamed, K
Current Medical Research and Opinion, 22(7): 1307-1310.
10.1185/030079906X112642
CrossRef
New England Journal of Medicine
Synergistic copathogens - HIV-1 and HSV-2
Corey, L
New England Journal of Medicine, 356(8): 854-856.

Molecular Medicine Reports
Herpes simplex virus: Drug resistance and new treatment options using natural products (Review)
Mundinger, TA; Efferth, T
Molecular Medicine Reports, 1(5): 611-616.
10.3892/mmr_00000001
CrossRef
Journal of Infectious Diseases
Impact of Acyclovir on Genital and Plasma HIV-1 RNA, Genital Herpes Simplex Virus Type 2 DNA, and Ulcer Healing among HIV-1-Infected African Women with Herpes Ulcers: A Randomized Placebo-Controlled Trial
Mayaud, P; LeGoff, J; Weiss, HA; Gresenguet, G; Nzambi, K; Bouhlal, H; Frost, E; Pepin, J; Malkin, JE; Hayes, RJ; Mabey, DCW; Belec, L
Journal of Infectious Diseases, 200(2): 216-226.
10.1086/599991
CrossRef
Jaids-Journal of Acquired Immune Deficiency Syndromes
Twenty-Five Years of HIV: Lessons for Low Prevalence Scenarios
Sawires, S; Birnbaum, N; Abu-Raddad, L; Szekeres, G; Gayle, J
Jaids-Journal of Acquired Immune Deficiency Syndromes, 51(): S75-S82.

Annual Review of Clinical Psychology
The Past, Present, and Future of HIV Prevention: Integrating Behavioral, Biomedical, and Structural Intervention Strategies for the Next Generation of HIV Prevention
Rotheram-Borus, MJ; Swendeman, D; Chovnick, G
Annual Review of Clinical Psychology, 5(): 143-167.
10.1146/annurev.clinpsy.032408.153530
CrossRef
Pharmacology & Therapeutics
Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides
Rusnati, M; Vicenzi, E; Donalisio, M; Oreste, P; Landolfo, S; Lembo, D
Pharmacology & Therapeutics, 123(3): 310-322.
10.1016/j.pharmthera.2009.05.001
CrossRef
American Journal of Public Health
Persistence and Change in Disparities in HIV Infection Among Injection Drug Users in New York City After Large-Scale Syringe Exchange Programs
Jarlais, DCD; Arasteh, K; Hagan, H; McKnight, C; Perlman, DC; Friedman, SR
American Journal of Public Health, 99(): S445-S451.
10.2105/AJPH.2008.159327
CrossRef
American Journal of Epidemiology
High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study
Brown, EL; Wald, A; Hughes, JP; Morrow, RA; Krantz, E; Mayer, K; Buchbinder, S; Koblin, B; Celum, C
American Journal of Epidemiology, 164(8): 733-741.
10.1093/aje/kwj270
CrossRef
British Journal of Hospital Medicine
The genitourinary complications of HIV infection in men
Masarani, M; Dinneen, M; Coyne, K; Hawkins, D
British Journal of Hospital Medicine, 69(3): 141-146.

Fertility and Sterility
Antiviral responses of human Fallopian tube epithelial cells to toll-like receptor 3 agonist poly(I : C)
Ghosh, M; Schaefer, TM; Fahey, JV; Wright, JA; Wira, CR
Fertility and Sterility, 89(): 1497-1506.
10.1016/j.fertnstert.2007.05.023
CrossRef
Antimicrobial Agents and Chemotherapy
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide
Pinna, D; Oreste, P; Coradin, T; Kajaste-Rudnitski, A; Ghezzi, S; Zoppetti, G; Rotola, A; Argnani, R; Poli, G; Manservigi, R; Vicenzi, E
Antimicrobial Agents and Chemotherapy, 52(9): 3078-3084.
10.1128/AAC.00359-08
CrossRef
AIDS Patient Care and Stds
Prevalence and incidence of sexually transmitted infections among South Indians at increased risk of HIV infection
Kumarasamy, N; Balakrishnan, P; Venkatesh, KK; Srikrishnan, AK; Cecelia, AJ; Thamburaj, E; Solomon, S; Mayer, KH
AIDS Patient Care and Stds, 22(8): 677-682.
10.1089/apc.2007.0166
CrossRef
International Journal of Std & AIDS
Prevalence and predictors of herpes simplex virus type 2 infection among female sex workers in Yunnan Province, China
Wang, HB; Wang, N; Chen, RY; Sharp, GB; Ma, YL; Wang, GX; Ding, GW; Wu, ZL
International Journal of Std & AIDS, 19(9): 635-639.
10.1258/ijsa.2008.008013
CrossRef
Jama-Journal of the American Medical Association
Risk factors for recent HIV infection in Uganda
Mermin, J; Musinguzi, J; Opio, A; Kirungi, W; Ekwaru, JP; Hladik, W; Kaharuza, F; Downing, R; Bunnell, R
Jama-Journal of the American Medical Association, 300(5): 540-549.

Journal of Infectious Diseases
Protection from Herpes Simplex Virus (HSV)-2 Infection with Replication-Defective HSV-2 or Glycoprotein D2 Vaccines in HSV-1-Seropositive and HSV-1-Seronegative Guinea Pigs
Hoshino, Y; Pesnicak, L; Dowdell, KC; Burbelo, PD; Knipe, DM; Straus, SE; Cohen, JI
Journal of Infectious Diseases, 200(7): 1088-1095.
10.1086/605645
CrossRef
Social Science & Medicine
Alcohol and transactional sex: How risky is the mix?
Norris, AH; Kitali, AJ; Worby, E
Social Science & Medicine, 69(8): 1167-1176.
10.1016/j.socscimed.2009.07.015
CrossRef
Journal of Immunology
Detailed Characterization of T Cell Responses to Herpes Simplex Virus-2 in Immune Seronegative Persons
Posavad, CM; Remington, M; Mueller, DE; Zhao, L; Magaret, AS; Wald, A; Corey, L
Journal of Immunology, 184(6): 3250-3259.
10.4049/jimmunol.0900722
CrossRef
Plos One
High GUD Incidence in the Early 20(th) Century Created a Particularly Permissive Time Window for the Origin and Initial Spread of Epidemic HIV Strains
de Sousa, JD; Muller, V; Lemey, P; Vandamme, AM
Plos One, 5(3): -.
ARTN e9936
CrossRef
Plos One
Sexual Risk Factors for HIV Infection in Early and Advanced HIV Epidemics in Sub-Saharan Africa: Systematic Overview of 68 Epidemiological Studies
Chen, L; Jha, P; Stirling, B; Sgaier, SK; Daid, T; Kaul, R; Nagelkerke, N
Plos One, 2(): -.
ARTN e1001
CrossRef
Plos One
HSV-2 Infection as a Cause of Female/Male and Racial/Ethnic Disparities in HIV Infection
Jarlais, DCD; Arasteh, K; McKnight, C; Perlman, DC; Cooper, HLF; Hagan, H
Plos One, 8(6): -.
ARTN e66874
CrossRef
Primary Care
Sexually Transmitted Diseases
Markle, W; Conti, T; Kad, M
Primary Care, 40(3): 557-+.
10.1016/j.pop.2013.05.001
CrossRef
Plos One
The Epidemiology of HIV and HSV-2 Infections among Women Participating in Microbicide and Vaccine Feasibility Studies in Northern Tanzania
Kapiga, SH; Ewings, FM; Ao, T; Chilongani, J; Mongi, A; Baisley, K; Francis, S; Andreasen, A; Hashim, R; Watson-Jones, D; Changalucha, J; Hayes, R
Plos One, 8(7): -.
ARTN e68825
CrossRef
Biomedical and Environmental Sciences
Herpes Simplex Virus Type 2 Risks in Female Sex Workers in the China-vietnam Border County of Hekou
Wang, JJ; Zhu, ZB; Yang, X; Wu, J; Wang, HB; Feng, L; Ding, GW; Norris, JL; Wang, N
Biomedical and Environmental Sciences, 25(6): 706-710.
10.3967/0895-3988.2012.06.013
CrossRef
Bmj Open
HIV incidence among men who have sex with men in Beijing: a prospective cohort study
Li, DL; Li, SM; Liu, YJ; Gao, YJ; Yu, MR; Yang, XY; Li, QC; Jiang, SL; Zhou, ZH; Zhang, Z; Yan, L; Jiang, GY; Xiao, D; Pan, SW; Luo, FJ; Ruan, YH; Shao, YM
Bmj Open, 2(6): -.
ARTN e001829
CrossRef
Antiviral Research
Poly (4-styrenesulfonic acid-co-maleic acid) is an entry inhibitor against both HIV-1 and HSV infections - Potential as a dual functional microbicide
Qiu, M; Chen, Y; Song, SW; Song, HY; Chu, Y; Yuan, ZP; Cheng, L; Zheng, DT; Chen, ZW; Wu, ZW
Antiviral Research, 96(2): 138-147.
10.1016/j.antiviral.2012.08.005
CrossRef
American Journal of Reproductive Immunology
Proinflammatory Cytokines and Chemokines - But not Interferon-beta - Produced in Response to HSV-2 in Primary Human Genital Epithelial Cells are Associated with Viral Replication and the Presence of the Virion Host Shutoff Protein
Ferreira, VH; Nazli, A; Mossman, KL; Kaushic, C
American Journal of Reproductive Immunology, 70(3): 199-212.
10.1111/aji.12133
CrossRef
Pharmaceutical Research
Decreasing Herpes Simplex Viral Infectivity in Solution by Surface-Immobilized and Suspended N,N-Dodecyl,methyl-polyethylenimine
Larson, AM; Oh, HS; Knipe, DM; Klibanov, AM
Pharmaceutical Research, 30(1): 25-31.
10.1007/s11095-012-0825-2
CrossRef
Drug and Alcohol Dependence
Public health strategies for prevention and control of HSV-2 in persons who use drugs in the United States
Semaan, S; Leinhos, M; Neumann, MS
Drug and Alcohol Dependence, 131(3): 182-197.
10.1016/j.drugalcdep.2013.03.013
CrossRef
Substance Use & Misuse
Sexual HIV/HSV-2 Risk Among Drug Users in New York City: An HIV Testing and Counseling Intervention
Pantin, M; Leonard, NR; Hagan, H
Substance Use & Misuse, 48(6): 438-445.
10.3109/10826084.2013.778279
CrossRef
International Journal of Std & AIDS
Herpes simplex virus type 2 infection as a biomarker for sexual debut among young people in sub-Saharan Africa: a literature review
Bastien, S; Mason-Jones, AJ; De Koker, P; Mmbaga, EJ; Ross, DA; Mathews, C
International Journal of Std & AIDS, 23(): 761-766.
10.1258/ijsa.2012.011433
CrossRef
American Journal of Reproductive Immunology
Female Genital Cutting and HIV Transmission: Is There an Association?
Diouf, K; Nour, N
American Journal of Reproductive Immunology, 69(): 45-50.
10.1111/aji.12028
CrossRef
American Journal of Reproductive Immunology
Genital immunology and HIV susceptibility in young women
Yi, TJ; Shannon, B; Prodger, J; McKinnon, L; Kaul, R
American Journal of Reproductive Immunology, 69(): 74-79.
10.1111/aji.12035
CrossRef
Journal of Infectious Diseases
Role of Seminal Shedding of Herpesviruses in HIV Type 1 Transmission
Gianella, S; Morris, SR; Vargas, MV; Young, JA; Callahan, B; Richman, DD; Little, SJ; Smith, DM
Journal of Infectious Diseases, 207(2): 257-261.
10.1093/infdis/jis683
CrossRef
International Journal of Std & AIDS
Association between herpes simplex virus type 2 and HIV-1 in a population of married couples from Dakar, Senegal
Camara, M; Seydi, M; Dieye, TN; Sow, PS; Mboup, S; Kestens, L; Jennes, W
International Journal of Std & AIDS, 23(): 810-814.
10.1258/ijsa.2012.011436
CrossRef
Viruses-Basel
Exploiting Herpes Simplex Virus Entry for Novel Therapeutics
Hadigal, S; Shukla, D
Viruses-Basel, 5(6): 1447-1465.
10.3390/v5061447
CrossRef
Proceedings of the National Academy of Sciences of the United States of America
Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody
Krawczyk, A; Arndt, MAE; Grosse-Hovest, L; Weichert, W; Giebel, B; Dittmer, U; Hengel, H; Jager, D; Schneweis, KE; Eis-Hubinger, AM; Roggendorf, M; Krauss, J
Proceedings of the National Academy of Sciences of the United States of America, 110(): 6760-6765.
10.1073/pnas.1220019110
CrossRef
Journal of Virology
Antiviral Activity of Trappin-2 and Elafin In Vitro and In Vivo against Genital Herpes
Drannik, AG; Nag, K; Sallenave, JM; Rosenthal, KL
Journal of Virology, 87(): 7526-7538.
10.1128/JVI.02243-12
CrossRef
Journal of Infectious Diseases
Reactivation of Herpes Simplex Virus Type 2 After Initiation of Antiretroviral Therapy
Tobian, AAR; Grabowski, MK; Serwadda, D; Newell, K; Ssebbowa, P; Franco, V; Nalugoda, F; Wawer, MJ; Gray, RH; Quinn, TC; Reynolds, SJ
Journal of Infectious Diseases, 208(5): 839-846.
10.1093/infdis/jit252
CrossRef
Expert Review of Vaccines
The challenge of developing a herpes simplex virus 2 vaccine
Dropulic, LK; Cohen, JI
Expert Review of Vaccines, 11(): 1429-1440.
10.1586/ERV.12.129
CrossRef
Plos Pathogens
A Multi-targeted Drug Candidate with Dual Anti-HIV and Anti-HSV Activity
Balzarini, J; Andrei, G; Balestra, E; Huskens, D; Vanpouille, C; Introini, A; Zicari, S; Liekens, S; Snoeck, R; Holy, A; Perno, CF; Margolis, L; Schols, D
Plos Pathogens, 9(7): -.
ARTN e1003456
CrossRef
Nature Medicine
Rapid host immune response and viral dynamics in herpes simplex virus-2 infection
Schiffer, JT; Corey, L
Nature Medicine, 19(3): 280-290.
10.1038/nm.3103
CrossRef
Virology
Varicella zoster vaccines and their implications for development of HSV vaccines
Gershon, AA
Virology, 435(1): 29-36.
10.1016/j.virol.2012.10.006
CrossRef
Plos One
HIV-DNA in the Genital Tract of Women on Long-Term Effective Therapy Is Associated to Residual Viremia and Previous AIDS-Defining Illnesses
Prazuck, T; Chaillon, A; Avettand-Fenoel, V; Caplan, AL; Sayang, C; Guigon, A; Niang, M; Barin, F; Rouzioux, C; Hocqueloux, L
Plos One, 8(8): -.
ARTN e69686
CrossRef
Plos One
Interacting Epidemics and Coinfection on Contact Networks
Newman, MEJ; Ferrario, CR
Plos One, 8(8): -.
ARTN e71321
CrossRef
Drug Development and Industrial Pharmacy
Evaluation of a 13-hexyl-berberine hydrochloride topical gel formulation
Wei, HL; Wang, SQ; Xu, F; Xu, LF; Zheng, JR; Chen, Y
Drug Development and Industrial Pharmacy, 39(4): 534-539.
10.3109/03639045.2012.687746
CrossRef
AIDS
Heterogeneity in host HIV susceptibility as a potential contributor to recent HIV prevalence declines in Africa
Nagelkerke, NJ; de Vlas, SJ; Jha, P; Luo, M; Plummer, FA; Kaul, R
AIDS, 23(1): 125-130.
10.1097/QAD.0b013e3283177f20
PDF (311) | CrossRef
AIDS
Transmission probabilities of HIV and herpes simplex virus type 2, effect of male circumcision and interaction: a longitudinal study in a township of South Africa
Mahiane, S; Legeai, C; Taljaard, D; Latouche, A; Puren, A; Peillon, A; Bretagnolle, J; Lissouba, P; Nguéma, EN; Gassiat, E; Auvert, B
AIDS, 23(3): 377-383.
10.1097/QAD.0b013e32831c5497
PDF (106) | CrossRef
AIDS
Disco funerals: a risk situation for HIV infection among youth in Kisumu, Kenya
Njue, C; Voeten, HA; Remes, P
AIDS, 23(4): 505-509.
10.1097/QAD.0b013e32832605d0
PDF (173) | CrossRef
AIDS
Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract
Rebbapragada, A; Wachihi, C; Pettengell, C; Sunderji, S; Huibner, S; Jaoko, W; Ball, B; Fowke, K; Mazzulli, T; Plummer, FA; Kaul, R
AIDS, 21(5): 589-598.
10.1097/QAD.0b013e328012b896
PDF (245) | CrossRef
AIDS
The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe
Averbach, SH; Gravitt, PE; Nowak, RG; Celentano, DD; Dunbar, MS; Morrison, CS; Grimes, B; Padian, NS
AIDS, 24(7): 1035-1042.
10.1097/QAD.0b013e3283377973
PDF (176) | CrossRef
AIDS
Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load
Baggaley, RF; Griffin, JT; Chapman, R; Hollingsworth, TD; Nagot, N; Delany, S; Mayaud, P; de Wolf, F; Fraser, C; Ghani, AC; Weiss, HA
AIDS, 23(8): 1005-1013.
10.1097/QAD.0b013e32832aadf2
PDF (763) | CrossRef
AIDS
No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa
Abu-Raddad, LJ; Longini, IM
AIDS, 22(9): 1055-1061.
10.1097/QAD.0b013e3282f8af84
PDF (190) | CrossRef
AIDS
Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men
Chin-Hong, PV; Husnik, M; Cranston, RD; Colfax, G; Buchbinder, S; Da Costa, M; Darragh, T; Jones, D; Judson, F; Koblin, B; Mayer, KH; Palefsky, JM
AIDS, 23(9): 1135-1142.
10.1097/QAD.0b013e32832b4449
PDF (246) | CrossRef
AIDS
Is vaginal washing associated with increased risk of HIV-1 acquisition?
van de Wijgert, J; Morrison, C; Salata, R; Padian, N
AIDS, 20(9): 1347-1348.
10.1097/01.aids.0000232252.74157.f9
PDF (2353) | CrossRef
AIDS
Incident HIV and herpes simplex virus type 2 infection among men in Rakai, Uganda
Tobian, AA; Ssempijja, V; Kigozi, G; Oliver, AE; Serwadda, D; Makumbi, F; Nalugoda, FK; Iga, B; Reynolds, SJ; Wawer, MJ; Quinn, TC; Gray, RH
AIDS, 23(12): 1589-1594.
10.1097/QAD.0b013e32832d4042
PDF (107) | CrossRef
AIDS
Herpes simplex virus type 2: a key role in HIV incidence
Glynn, JR; Biraro, S; Weiss, HA
AIDS, 23(12): 1595-1598.
10.1097/QAD.0b013e32832e15e8
PDF (106) | CrossRef
AIDS
Foreskin inflammation is associated with HIV and herpes simplex virus type-2 infections in Rakai, Uganda
Johnson, KE; Sherman, ME; Ssempiija, V; Tobian, AA; Zenilman, JM; Duggan, MA; Kigozi, G; Serwadda, D; Wawer, MJ; Quinn, TC; Rabkin, CS; Gray, RH
AIDS, 23(14): 1807-1815.
10.1097/QAD.0b013e32832efdf1
PDF (718) | CrossRef
Current Opinion in Infectious Diseases
Sexual networks and the transmission of drug-resistant HIV
Drumright, LN; Frost, SD
Current Opinion in Infectious Diseases, 21(6): 644-652.
10.1097/QCO.0b013e328318977c
PDF (179) | CrossRef
JAIDS Journal of Acquired Immune Deficiency Syndromes
Anal Sexually Transmitted Infections and Risk of HIV Infection in Homosexual Men
Jin, F; Prestage, GP; Imrie, J; Kippax, SC; Donovan, B; Templeton, DJ; Cunningham, A; Mindel, A; Cunningham, PH; Kaldor, JM; Grulich, AE
JAIDS Journal of Acquired Immune Deficiency Syndromes, 53(1): 144-149.
10.1097/QAI.0b013e3181b48f33
PDF (99) | CrossRef
JAIDS Journal of Acquired Immune Deficiency Syndromes
Bacterial Vaginosis and Vaginal Yeast, But Not Vaginal Cleansing, Increase HIV-1 Acquisition in African Women
Padian, NS; van de Wijgert, JH; Morrison, CS; Cornelisse, PG; Munjoma, M; Moncada, J; Awio, P; Wang, J; Van der Pol, B; Chipato, T; Salata, RA
JAIDS Journal of Acquired Immune Deficiency Syndromes, 48(2): 203-210.
10.1097/QAI.0b013e3181743936
PDF (98) | CrossRef
JAIDS Journal of Acquired Immune Deficiency Syndromes
The Potential Role of Biomarkers in HIV Preventive Vaccine Trials
MacLachlan, E; Mayer, KH; Barnabas, R; Sanchez, J; Koblin, B; Duerr, A
JAIDS Journal of Acquired Immune Deficiency Syndromes, 51(5): 536-545.
10.1097/QAI.0b013e3181adcbbe
PDF (143) | CrossRef
JAIDS Journal of Acquired Immune Deficiency Syndromes
Gender Differences in Sex Risk Behaviors Among Ukraine Injection Drug Users
Booth, RE; Lehman, WE; Brewster, JT; Sinitsyna, L; Dvoryak, S
JAIDS Journal of Acquired Immune Deficiency Syndromes, 46(1): 112-117.
10.1097/QAI.0b013e318141f965
PDF (100) | CrossRef
JAIDS Journal of Acquired Immune Deficiency Syndromes
Group Sex Events and HIV/STI Risk in an Urban Network
Friedman, SR; Bolyard, M; Khan, M; Maslow, C; Sandoval, M; Mateu-Gelabert, P; Krauss, B; Aral, SO
JAIDS Journal of Acquired Immune Deficiency Syndromes, 49(4): 440-446.
10.1097/QAI.0b013e3181893f31
PDF (277) | CrossRef
JAIDS Journal of Acquired Immune Deficiency Syndromes
Risk Factors for Herpes Simplex Virus Type 2 and HIV Among Women at High Risk in Northwestern Tanzania: Preparing for an HSV-2 Intervention Trial
Watson-Jones, D; Weiss, HA; Rusizoka, M; Baisley, K; Mugeye, K; Changalucha, J; Everett, D; Balira, R; Knight, L; Ross, D; Hayes, RJ
JAIDS Journal of Acquired Immune Deficiency Syndromes, 46(5): 631-642.
10.1097/QAI.0b013e31815b2d9c
PDF (190) | CrossRef
Sexually Transmitted Diseases
Sexually Transmitted Infections as Risk Factors for HIV Infection Among MSMs: Systematic Review
Bonell, C; Hickson, F; Beaumont, M; Weatherburn, P
Sexually Transmitted Diseases, 35(2): 209.
10.1097/OLQ.0b013e318164cbc3
PDF (54) | CrossRef
Sexually Transmitted Diseases
HIV Incidence Rates and Risk Factors for Urban Women in Zambia: Preparing for a Microbicide Clinical Trial
Kapina, M; Reid, C; Roman, K; Cyrus-Cameron, E; Kwiecien, A; Weiss, S; Vermund, SH
Sexually Transmitted Diseases, 36(3): 129-133.
10.1097/OLQ.0b013e318190191d
PDF (179) | CrossRef
Sexually Transmitted Diseases
Seroprevalence and Risk Factors for Herpes Simplex Virus Infection in a Population of HIV-Infected Patients in Canada
Romanowski, B; Myziuk, LN; Walmsley, SL; Trottier, S; Singh, AE; Houston, S; Joffe, M; Chiu, I
Sexually Transmitted Diseases, 36(3): 165-169.
10.1097/OLQ.0b013e31818d3fb6
PDF (178) | CrossRef
Sexually Transmitted Diseases
Biomarkers of Cervicovaginal Inflammation for the Assessment of Microbicide Safety
Cummins, JE; Doncel, GF
Sexually Transmitted Diseases, 36(3): S84-S91.
10.1097/OLQ.0b013e3181994191
PDF (549) | CrossRef
Sexually Transmitted Diseases
Herpes Simplex Virus Type 2 Infection in Young Adult Women: Risk Factors for Infection and Frequency of Viral Shedding
Fife, KH; Williams, JA; Thomas, AL; Ofner, S; Katz, BP; Fortenberry, JD
Sexually Transmitted Diseases, 37(4): 248-252.
10.1097/OLQ.0b013e3181d4f866
PDF (181) | CrossRef
Sexually Transmitted Diseases
Herpes Simplex Virus Type 2 (HSV-2) Infection in Women Attending an Antenatal Clinic in the South Pacific Island Nation of Vanuatu
Haddow, LJ; Sullivan, EA; Taylor, J; Abel, M; Cunningham, AL; Tabrizi, S; Mindel, A
Sexually Transmitted Diseases, 34(5): 258-261.
10.1097/01.olq.0000237774.29010.30
PDF (229) | CrossRef
Sexually Transmitted Diseases
Population Level Impact of an Imperfect Prophylactic Vaccine for Herpes Simplex Virus-2
Alsallaq, R; Schiffer, J; Longini, I; Wald, A; Corey, L; Abu-Raddad, L
Sexually Transmitted Diseases, 37(5): 290-297.
10.1097/OLQ.0b013e3181d3d023
PDF (440) | CrossRef
Sexually Transmitted Diseases
Suppressive Therapy With Valacyclovir in Early Genital Herpes: A Pilot Study of Clinical Efficacy and Herpes-Related Quality of Life
Handsfield, HH; Warren, T; Werner, M; Phillips, JA
Sexually Transmitted Diseases, 34(6): 339-343.
10.1097/01.olq.0000243620.13718.56
PDF (281) | CrossRef
Sexually Transmitted Diseases
Seroprevalence of Herpes Simplex Virus Type 2 and Characteristics Associated With Undiagnosed Infection: New York City, 2004
Schillinger, JA; McKinney, CM; Garg, R; Gwynn, RC; White, K; Lee, F; Blank, S; Thorpe, L; Frieden, T
Sexually Transmitted Diseases, 35(6): 599-606.
10.1097/OLQ.0b013e3181666fb1
PDF (299) | CrossRef
Sexually Transmitted Diseases
Disentangling Contributions of Reproductive Tract Infections to HIV Acquisition in African Women
van de Wijgert, JH; Morrison, CS; Brown, J; Kwok, C; Van Der Pol, B; Chipato, T; Byamugisha, JK; Padian, N; Salata, RA
Sexually Transmitted Diseases, 36(6): 357-364.
10.1097/OLQ.0b013e3181a4f695
PDF (268) | CrossRef
Sexually Transmitted Diseases
Riddle of the Sphinx Revisited: The Role of STDs in HIV Prevention
Barnabas, RV; Wasserheit, JN
Sexually Transmitted Diseases, 36(6): 365-367.
10.1097/OLQ.0b013e3181a4f6ac
PDF (114) | CrossRef
Sexually Transmitted Diseases
Risk Factors for Incident Herpes Simplex Type 2 Virus Infection Among Women Attending a Sexually Transmitted Disease Clinic
GALLO, MF; WARNER, L; MACALUSO, M; STONE, KM; BRILL, I; FLEENOR, ME; HOOK, EW; AUSTIN, HD; LEE, FK; NAHMIAS, AJ
Sexually Transmitted Diseases, 35(7): 679-685.
10.1097/OLQ.0b013e31816fcaf8
PDF (243) | CrossRef
Sexually Transmitted Diseases
Performance of Focus ELISA Tests for HSV-1 and HSV-2 Antibodies Among University Students With No History of Genital Herpes
Mark, HD; Nanda, JP; Roberts, J; Rompalo, A; Melendez, JH; Zenilman, J
Sexually Transmitted Diseases, 34(9): 681-685.
10.1097/01.olq.0000258307.18831.f0
PDF (179) | CrossRef
Sexually Transmitted Diseases
HSV-2 Serologic Testing in an HMO Population: Uptake and Psychosocial Sequelae
Richards, J; Scholes, D; Caka, S; Drolette, L; Magaret, AM; Yarbro, P; Lafferty, W; Crosby, R; Diclemente, R; Wald, A
Sexually Transmitted Diseases, 34(9): 718-725.
10.1097/01.olq.0000261455.60955.59
PDF (727) | CrossRef
Sexually Transmitted Diseases
Clients of Female Sex Workers in Gonaives and St-Marc, Haiti Characteristics, Sexually Transmitted Infection Prevalence and Risk Factors
Couture, M; Soto, JC; Akom, E; Labbé, A; Joseph, G; Zunzunegui, M
Sexually Transmitted Diseases, 35(10): 849-855.
10.1097/OLQ.0b013e318177ec5c
PDF (237) | CrossRef
Sexually Transmitted Diseases
Herpes Simplex Virus Type-2 Seropositivity Among Ever Married Women in South and North Vietnam: A Population-Based Study
Le, HV; Schoenbach, VJ; Herrero, R; Hoang Pham, AT; Nguyen, HT; Nguyen, TT; Muñoz, N; Franceschi, S; Vaccarella, S; Parkin, MD; Snijders, PJ; Morrow, RA; Smith, JS
Sexually Transmitted Diseases, 36(10): 616-620.
10.1097/OLQ.0b013e3181a8cde4
PDF (179) | CrossRef
Sexually Transmitted Diseases
Herpes Simplex Virus-2 and HIV Among Noninjecting Drug Users in New York City
Des Jarlais, DC; Hagan, H; Arasteh, K; McKnight, C; Perlman, D; Friedman, SR
Sexually Transmitted Diseases, 34(11): 923-927.
10.1097/OLQ.0b013e3180ca9647
PDF (179) | CrossRef
Sexually Transmitted Diseases
Screening for HSV-2 Infection in STD Clinics and Beyond: A Few Answers But More Questions
Douglas, JM; Berman, SM
Sexually Transmitted Diseases, 36(11): 729-731.
10.1097/OLQ.0b013e3181c04dea
PDF (112) | CrossRef
Back to Top | Article Outline
Keywords:

systematic review; meta-analysis; HSV-2; HIV; follow-up

© 2006 Lippincott Williams & Wilkins, Inc.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.